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Abstract 
Osteoarthritis (OA) is a painful degenerative joint disease that affects millions of North 
Americans.  OA could be better managed if tissue engineers can develop methods to create long-
term mechanically stable engineered articular cartilage tissue substitutes. Many of the tissue 
engineered cartilage constructs currently available lack the chemical stimuli, cell-friendly 
environment, and/or mechanical strength needed for use in joint cartilage repair. The goal of my 
research was to test the efficacy of composite scaffolds comprised of a solid synthetic polymer 
framework impregnated with a fibrin/alginate hydrogel containing hyaluronic acid (HA) and/or 
chondroitin sulphate supplements (CS). 
The suitability of a polylactic-co-glycolic acid (PLGA) and iron(III) oxide material slurry 
as the synthetic polymer framework was determined. It was found that a solid three-dimensional 
scaffold with an interconnected porous structure could be fabricated from this material using 
dispensing-based rapid prototyping. Moreover, films of the PLGA-iron oxide material supported 
higher cell populations of porcine chondrocytes compared to a previously reported PLGA-
hydroxyapatite material film. In addition, an experiment examining the effects of HA and/or CS 
macromolecule supplementation on chondrocytes cultured in a fibrin-alginate hydrogel was 
performed. Chondrocytes cultured in fibrin-alginate hydrogels retained their phenotype better 
than chondrocytes cultured in monolayer as analysis of expression of type I collagen and type II 
collagen mRNA transcripts.  HA or CS supplementation of the hydrogels increased matrix 
production during the first week of culture. However, the effects of these supplements on matrix 
accumulation were not additive and were no longer observed after 2 weeks of culture. 
Supplementation of the hydrogels with HA and/or CS increased the chondrocyte cell population 
after two weeks of culture, and the effects of these macromolecule on cell numbers were 
additive. Finally, composite scaffolds were successfully fabricated by impregnating the solid 
PLGA-iron oxide scaffold with a CS-supplemented fibrin-alginate hydrogel. However, a large 
amount of cell death that occurred during the cell seeding prevented quantification of cellular 
DNA or sulphated GAG accumulation in these composite scaffolds. Nevertheless, my research 
suggests that, with refinement of the cell seeding process, a CS supplemented fibrin-
alginate/PLGA-iron oxide composite may be a superior three-dimensional scaffold system for 
use in articular cartilage tissue engineering applications.  
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Chapter 1: Introduction 
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1.1 Adult Articular Cartilage and Osteoarthritis 
Adult articular cartilage is a complex, organized tissue made up of numerous components 
such as collagens, proteoglycans, and chondrocytes. These components work together to form a 
tissue that can withstand the heavy biomechanical loads normally applied to articular cartilage. 
The main component of cartilage is water, which constitutes 70-85% of its total weight. 
The next most prevalent component is collagen, making up between 60 and 70% of the dry 
weight[1]. Collagen gives structure and tensile/shear strength to cartilage. The collagen matrix is 
primarily made up of collagen type II fibrils which have small amounts of collagen types IX and 
XI associated with them. In addition collagen types I, III, V, VI, XII, and XIV are also present to 
a much lesser degree[2, 3]. 
Proteoglycans are also heavily concentrated within the cartilage extra-cellular matrix 
(ECM), making up approximately 30% of the dry weight[1, 2]. Both non-aggregating and 
aggregating proteoglycans (PG) are present in cartilage. Aggregating PG are made up of a large 
number of sulfated glycosaminoglycans (GAG) such as keratan sulfate, chondroitin sulfate, and 
dermatan sulfate attached laterally to the core protein aggrecan. These aggregating PG are bound 
to a hyaluronic acid (HA) backbone via Link Protein. Non-aggregating PG, such as decorin or 
biglycan, consist of a core protein (not aggrecan) with a relatively small number of GAG 
attached laterally. The GAG interact with the water present in cartilage matrix, providing flow 
resistance, which results in the cartilage becoming extremely stiff when subjected to impact 
loading[2]. 
The aforementioned ECM components almost completely account for the composition of 
adult hyaline cartilage. The chondrocytes responsible for producing these components make up 
only approximately 2% of the cartilage’s total volume[4]. A population of healthy, differentiated 
chondrocytes would be expected to produce high levels of collagen type II and aggregating PG. 
On the other hand, expression of collagen type I (rather than collagen type II) is often interpreted 
as a marker of chondrocyte de-differentiation, which in this context means a change in cell shape 
and protein expression. 
Osteoarthritis (OA) is a debilitating degenerative joint disease involving the degradation 
of the articular cartilage at the distal ends of bones. There are two types of OA. Primary OA 
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describes cases with no identifiable cause. Secondary OA cases are usually the result of acute 
injury to the articular cartilage[5], whereas primary OA could result from a slow age-related 
erosion of the joint cartilage associated with a decrease in the tissue’s  proteoglycan content [6]. 
Eventually this degraded cartilage leads to bone-on-bone contact, making OA a painful and 
sometimes debilitating disease, and one that affects the day to day lives of millions of North 
Americans[7]. Over 50% of people over the age of 65 are affected by OA[8], representing an 
annual $65 billion dollar burden on the US economy alone, both from medical costs and lost 
wages[9]. In addition to the monetary costs, there are the emotional costs carried by patients and 
their families. Therefore, there is much incentive to find a method to regenerate articular 
cartilage to repair the joints of OA patients. 
There are a number of established methods that have been used to repair joints of patients 
suffering from OA. One method drills to the subchondral bone, releasing mesenchymal stem 
cells (MSCs) from the bone marrow into the cartilage lesion. The MSCs will form a fibrin clot 
and will start to proliferate and produce their own ECM[10, 11]. Another method is autologous 
chondrocyte transplantation (ACT), which has been performed on over 12,000 patients 
worldwide[12]. In this procedure chondrocytes from a non-load bearing portion of the joint are 
removed from the patient, expanded in monolayer, and placed in a suspension which is 
subsequently injected into the cartilage lesion. ACT has problems with donor site morbidity[10], 
and both ACT and subchondral drilling produce cartilage that is mechanically inferior to the 
surrounding native cartilage[10, 13]. 
A promising alternative is cartilage tissue engineering, which is aimed at repairing 
articular cartilage lesions with artificial cartilage constructs that have mechanical properties 
similar to those of native cartilage tissue. Tissue engineering in general is an interdisciplinary 
field combining engineering, biology, and materials science, with the goal of replacing damaged 
or diseased tissue with artificial tissue substitutes grown in a lab. In most cases, tissue engineers 
seed a biocompatible three-dimensional (3D) construct called a scaffold with a cell suspension. 
This scaffold provides initial mechanical support for the cells, as well as providing a micro-
environment that supports cell proliferation and a differentiated phenotype. Eventually, the cells 
produce their own ECM capable of withstanding the biomechanical loads the tissue is subjected 
to in-vivo while the scaffolds biodegrade away, leaving only the engineered tissue. If tissue 
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engineers succeed in producing a cartilage implant with mechanical properties and composition 
near those of natural hyaline cartilage, these could be used to effectively fill in cartilage lesions. 
Filling these lesions with engineered cartilage will be a significantly more effective method of 
treating OA compared to those used today, such as ACI and prosthetics. 
1.2 Brief Introduction to Cartilage Tissue Engineering 
1.2.1 Stimulation of Chondrocytes with Macromolecules 
A variety of molecules have been used to help chondrocytes increase ECM output, 
proliferate, and/or maintain their phenotype[2]. For example, different types of transforming 
growth factor betas [14-17] and bone morphogenetic proteins [15, 18, 19] have been widely used 
in cartilage tissue engineering. In addition, both fibroblast growth factor 2 (FGF-2) and insulin-
like growth factor 1 have also been shown to help chondrocytes maintain their phenotype in 
traditional monolayer culture conditions[15, 17]. These growth factors are small peptides which 
interact with receptors on the cell surface which directly affect cytoplasmic protein kinase 
pathways[20]. 
HA and chondroitin sulphate (CS) are both components found in natural cartilaginous 
tissue. It has been shown that the addition of HA to cell medium or hydrogel enhances the 
production of GAG and collagen type II, as well as significantly increasing cell proliferation[21, 
22]. In addition, chondroitin sulphate has been shown to increase cell proliferation and PG 
synthesis[23, 24]. Both HA and CS are much larger than the aforementioned growth factors and 
are known as macromolecules. These macromolecules also interact with receptors on the 
surfaces, which are in turn associated with the cells’ cytoskeleton. This stimulation of the 
cytoskeleton will ultimately also lead to downstream effects on cytoplasmic protein 
pathways[20]. 
While the effects of HA and CS on chondrocytes have been studied previously, there has 
been no investigation to determine if the effects of these molecules on chondrocyte proliferation 
and matrix synthesis is additive or not. If these molecules have additive effects or interact 
synergistically with one another, it may be worth the extra expense of adding both of them to 
engineered cartilage cultures before implantation. On the other hand, if they interfere with one 
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another supplementing the cartilage cultures with both molecules may actually result in less 
desirable chondrocyte behaviour than if one just supplemented with CS or HA on their own. 
1.2.2 Hydrogels 
A hydrogel is a water swollen polymer network which can be used for drug delivery or as 
a 3D matrix to support cellular growth and differentiation. Typically, hydrogels exist as viscous 
liquids unless the cross-linking process is performed to cause polymerization. Different cross-
linking methods include: chemical cross-linking[25], photopolymerization[26], and enzymatic 
cross-linking[27]. These hydrogels can take the shape of any mould they are polymerized in, 
making them potential candidates for injectable tissue-engineered constructs (TEC). 
A number of materials have been used as hydrogels in cartilage tissue engineering, and 
Table 1 summarizes the common hydrogels reported in the literature. Both alginate and agarose 
are polysaccharides that are extracted from brown and red algae, respectively. Chitosan is 
fabricated by the deacetylation of chitin, which is a naturally derived polysaccharide from 
arthropod exoskeletons[28]. Finally, fibrinogen, which is found naturally within mammalian 
blood and cleaved by thrombin into fibrin during blood coagulation can also function as a 
hydrogel[29]. 
Table 1. Various biomaterials used in hydrogels for cartilaginous TECs. Almost all hydrogel materials are 
some form of biologically-derived polymer and have low mechanical properties. 
Notably, fibrin has numerous advantages over many of the other hydrogels listed in Table 
1. It has been shown that fibrin supports higher cell proliferation than alginate[42]. In addition, 
as it is naturally found in the body, fibrin can decrease the chance of an immune response[29]. It 
also has cell adhesion capabilities through its linkage to the integrin receptor[43], and will 
Biomaterial Natural or Synthetic References 
Hydrogels   
Alginate Natural [21, 25, 30-32] 
Agarose Natural [33-35] 
Collagen Natural [36-38] 
Hyaluronic Acid Natural [21, 37, 39] 
Fibrin Glue Natural [16, 40] 
Gelatin Natural [39] 
Chondroitin Sulfate Natural [26, 39] 
Poly(vinyl alcohol) Synthetic [26] 
Chitosan Natural [41] 
6 
 
biodegrade unlike alginate[42]. The use of fibrin in cell scaffolds has been shown to help retain 
macromolecules within the hydrogel[43] thus stimulating chondrocyte activity. However, the 
rapid degradation rate of fibrin can cause chondrocytes to de-differentiate[44]. This rapid 
degradation can be slowed by the addition of more stable hydrogels such as alginate[42], or the 
addition of macromolecules like HA[45]. 
Given the long-term stability and biocompatibility of a fibrin-alginate hydrogel, it is ideal 
for 3D cell culture and as such could be used to support cells while investigating the effects of 
macromolecule supplementation (Section 1.2.1). 
1.2.3 Scaffolds and their Fabrication 
Like hydrogels, there are numerous different types of polymers that have been used to 
create solid scaffolds, as shown in Table 2. There are a number of different fabrication methods 
used to form these polymers into scaffolds. Some of these methods include porogen 
leaching[36], freeze-drying[36, 39], electrospinning[46], and rapid-prototyping (RP) 
methods[16, 47, 48]. Unlike the other types of scaffold fabrication, RP allows for accurate 
control over pore-size and orientation, which can be created reproducibly.  
Table 2. Various synthetic polymers used to create solid tissue engineering scaffolds. 
The RP technique currently being used at the University of Saskatchewan for tissue 
engineering is one based on dispensing[53], in which scaffolds are created by extruding a 
polymer through and then out a needle, as shown in Figure 1. The material extruded is either 
Biomaterial Natural or Synthetic References 
Solid Polymers   
Poly(L-lactide) (PLA) Synthetic [49] 
Poly(ethylene glycol)-
terephthalate-poly(butylene 
terephthalate) (PEGT/PBT) 
Synthetic [50] 
Poly(propylene fumarate) 
(PPF) Synthetic [37] 
Polyurethane Synthetic [40] 
Polyethyleneoxide-
terephtalate/ polybutylene-
terephtelate (PEOT/PBT) 
Synthetic [51] 
Poly(D,L-lactide-co-
glycolide) (PLGA) Synthetic [36, 39, 52] 
Polyglycolic acid (PGA) Synthetic [52] 
Polycaprolactone (PCL) Synthetic [16] 
7 
 
molten[47] or in a material slurry[48]. Materials that have been used in this fabrication process 
include PEGT/PBT[50], PCL[54], PLA[48, 54], and PLGA[54, 55]. Of these materials, PLGA 
has some distinct advantages over the rest. First, PEGT/PBT requires high temperatures[47] (not 
currently achievable at the U of S) to extrude it, while PLGA, PCL and PLA are usually mixed 
with a solvent such as chloroform, and a non-soluble nano-sized particle to create a material 
slurry[48, 54, 55]. PCL degrades very slowly, taking more than three years as opposed to the 
months that it takes for PLA and PLGA to degrade[56]. Finally, PLGA and its copolymers PLA 
and PGA have been widely used in cartilage tissue engineering[52, 55, 57-60] and as dissolvable 
clinical sutures[61]. By varying the copolymer concentrations in PLGA, the mechanical and 
degradation properties can be more finely tuned than if one used PLA or PGA alone[56].  
Figure 1. Schematic showing the dispensing-based RP technique. The computer controls the stepping motors 
to move the syringe in a pre-programmed path as the scaffold material is extruded through the needle. The 
layers are sequentially deposited on top of one another to create a 3D construct. 
The purpose of the aforementioned non-soluble nano-sized particles in the material slurry 
is to adjust the consistency such that overhanging structures (i.e. interconnected pores) can be 
created during RP. Hydroxyapatite (HAP) has previously been used as the micro-sized particle in 
bone tissue engineering applications[48, 55, 62, 63]. However, the fact that HAP is found in 
bone rather than hyaline cartilage raises the concern that it might cause chondrocytes to de-
differentiate. A promising alternative to HAP is the use of iron oxide nanoparticles, which have 
extremely low solubility at physiological pH[64], no cytotoxic effects[65], no effect on 
chondrocyte phenotype[66]. As such, they have been approved by the FDA as an MRI contrast 
agent[67]. 
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The proven suitability of PLGA in cartilage tissue engineering and the biocompatibility 
of iron oxide particles suggest that a slurry comprised of these two materials could be used to 
create a solid scaffold capable of providing mechanical support to a 3D chondrocyte culture. 
Several strategies for combining the mechanical stability of a solid scaffold with the cell-
friendly environment of a hydrogel have been tested during the past ten years. Compared to solid 
scaffolds alone, it has been shown that these composite scaffolds are more successful at growing 
cartilaginous tissue. For example, GAG[31, 40, 57, 59] and collagen type II[31, 68] production 
per cell is higher in composite scaffolds. In addition, cell proliferation in composite scaffolds is 
significantly higher than in solid scaffold controls, but not significantly different than in 
hydrogels alone[40]. 
Commonly, the composite scaffolds found in the literature use a fibrin hydrogel[40, 57, 
68, 69]. As mentioned in section 1.2.2, it has been shown that fibrin alone will rapidly degrade 
leading to chondrocyte de-differentiation. Based on the properties of alginate it would be 
beneficial to use a fibrin-alginate mixture[42] to improve the composite scaffolds by enhancing 
the longevity of the hydrogel component. In addition, there exists a void in the literature 
regarding a solid scaffold material used for cartilaginous composite scaffolds that can be 
deposited as a material slurry rather than a high temperature melt. 
These solid scaffolds should greatly enhance the mechanical properties of the TEC. 
However, there has been little work done to determine the mechanical properties of these 
composite scaffolds. In fact, one of the few examples of mechanical testing of these scaffolds 
fails to examine widely reported cartilage properties such as aggregate modulus and hydraulic 
permeability[59], which would be of importance to cartilage tissue engineering. 
1.3 Research Goal and Objectives 
It is hypothesized that for the reasons postulated in Section 1.2.3, chloroform-solubilised 
PLGA mixed with iron oxide nanoparticles can prove a suitable material for the solid scaffold 
component of composite scaffolds. The goal of this research is to fabricate composite scaffolds 
from the above material impregnated with a macromolecule-supplemented fibrin/alginate 
hydrogel and to characterize them in terms of chondrocyte phenotype retention and proliferation 
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as compared to PLGA and iron oxide solid scaffold alone. To achieve this goal, the following 
specific objectives are proposed: 
1. Fabricate scaffolds from a material slurry comprised of PLGA and iron oxide and 
characterize them by 
a. performing a microtomography examination of the solid scaffolds to determine the actual 
average pore size and ensure the consistency of the internal overhanging structures (i.e. 
interconnected pores) and, 
b. culturing primary chondrocytes on this material and comparing cell survivability to that of 
a similar material that uses HAP as the micro-sized particle, and a conventional tissue 
culture plate. 
2. To identify the combination of CS and HA that best stimulates chondrocyte activity, as 
determined by 
a. the amount of PG, collagen types I and II produced and expressed as mRNA and, 
b. the amount of cell proliferation and PG matrix accumulation. 
3. Perform a preliminary experiment showing that chondrocytes can be cultured within the 
composite scaffolds by 
a. measuring PG production and cell population and, 
b. comparing these measurements to solid scaffold controls 
1.4 Organization of this Thesis 
This thesis is organized into five separate chapters: Introduction; Mechanical Properties 
of Natural Cartilage and Tissue-Engineered Constructs; Materials and Methods; Results; and 
General Discussion. These chapters are followed by a References section which lists all cited 
sources. 
Chapter 2 is a publication which was accepted by Tissue Engineering Part B: Reviews in 
early 2011. A description of the relevance of this manuscript to the project as a whole is briefly 
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outlined at the beginning of the Chapter. Chapter 3 outlines the methodology used during all 
experimental work reported in this thesis and Chapter 4 presents the results from said 
experiments. Finally, the discussion in Chapter 5 examines these results and compares them to 
previously reported findings. In addition, it draws come conclusions about the import of this 
work and makes some suggestions for future experiments which could help clarify some of the 
observed relationships. 
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Chapter 2: Mechanical Properties of Natural 
Cartilage and Tissue-Engineered 
Constructs 
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2.1 Relevance of this Manuscript within the General Project 
As mentioned in Section 1.2.3, one of the primary benefits of using composite scaffolds 
compared to a hydrogel is the mechanical robustness of the solid scaffold. As such, it will be of 
great importance to characterize the mechanical properties of these composite scaffolds and 
compare them to the mechanical properties of natural articular cartilage. 
Due to the importance of this mechanical characterization, it was initially included as a 
part of this Master’s project. As such, an extensive literature review was performed on both the 
mechanical properties of natural cartilage and TECs and the mechanical tests used to ascertain 
these properties. This literature review has led to a paper[70] published in August of 2011 in 
Tissue Engineering Part B: Reviews, a leading journal in the field with an impact factor of 4.636. 
It is reprinted as a chapter in this thesis with permission from Mary Anne Liebert, Inc. It is noted 
that this paper is co-authored and that it is the mutual understanding of all authors that Chris 
Little, as the first author, made primary contribution to its publication. The contributions of the 
other authors are acknowledged. 
As a further note, due to the fact that the work presented in other chapters in this thesis is 
sufficient for a Master’s project, the mechanical testing potion of the project was not pursued, as 
approved by the Advisory Committee. Testing the mechanical properties of scaffolds is crucial to 
the success of cartilage tissue engineering applications and as such the aforementioned review 
paper is included to aid future researchers or students who will build on the work presented in 
this thesis. 
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2.2 Manuscript 
2.2.1 Abstract 
There has been much research over the past two decades with the aim of engineering 
cartilage constructs for repairing or restoring damaged cartilage. To engineer healthy 
neocartilage, the constructs must have mechanical properties matching those of native cartilage 
as well as appropriate for the loading conditions of the joint. This paper discusses the mechanical 
behaviour of native cartilage and surveys different types of tensile, compressive, and shear tests 
with their limitations. It also comprehensively reviews recent work and achievements in 
developing the mathematical models representing the mechanical properties of both native and 
engineered cartilage. Different methods for enhancing the mechanical properties of engineered 
cartilage are also discussed, including scaffold design, mechanical stimulation, and chemical 
stimulation. This paper concludes with recommendations for future research aimed at achieving 
engineered cartilage with mechanical properties matching those found in native cartilage.  
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2.2.2 Introduction 
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive erosion of 
the articular cartilage that covers the distal surfaces of bones. Because articular cartilage is 
responsible for cushioning compressive forces in the joint, its destruction leads to joint pain, 
stiffness, and impaired mobility. Currently, OA afflicts the daily life of millions of Americans 
[7] whose articular cartilage has been damaged either through trauma or the effects of aging [5]. 
In addition to the emotional costs carried by patients and families dealing with this disability 
those, who suffer from this disease represent a large burden on both the economy and the health 
care system, as lost wages and medical costs related to OA are estimated to be as much as $65 
billion in the US alone [9]. Therefore, it is desirable to develop technologies that would allow for 
regeneration of damaged articular cartilage. 
Tissue engineering aims to replace damaged tissues with artificial tissues grown in the 
controlled laboratory environment. For this, three-dimensional (3D) constructs, or scaffolds, are 
created from biocompatible and biodegradable materials and then seeded with cells such as 
chondrocytes. The scaffold provides cells with a 3D structure and mechanical support for their 
attachment and proliferation, ultimately growing into a functional tissue engineering construct 
(TEC). The TEC is then implanted into a patient and, with time, hopefully integrates itself with 
the surrounding natural cartilage. Eventually, the cells will secrete their own extra-cellular matrix 
(ECM) that is able to withstand the mechanical forces seen in the joints, while the scaffold 
biodegrades. In this healing process, a crucial role is played by the mechanical properties of the 
TEC, which, ideally, must match those of native cartilage. Considerable progress has been made 
in the past two decades to fulfill the requirement of mechanical properties imposed on the TEC 
as applied to the repair of damaged cartilage. This paper aims to review this progress with 
emphasis on the different mechanical testing procedures, mathematical representations or models 
of the mechanical properties of cartilage and TECs, and methods to enhance the mechanical 
properties of TECs. The challenges in these aspects are also discussed, along with the 
recommendations for future research aimed at achieving the desired mechanical properties of 
TECs for cartilage tissue engineering applications.  
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2.2.3 Cartilage Structure and Response to Mechanical Forces 
2.2.3.1 Organization and Composition of Adult Articular Cartilage 
Articular cartilage is an organized tissue composed mainly of water, collagens, 
proteoglycans, and chondrocytes. These components interact with one another to give cartilage 
the strength to withstand the mechanical forces or loads it experiences. Water, the most prevalent 
component, accounts for 70-85% of the total weight of articular cartilage; next is collagen, which 
makes up between 60 and 70% of the cartilage’s dry weight [1]. Collagen type II makes up most 
of the collagen matrix, in addition to types I, III, V, VI, IX, XI, XII, and XIV to lesser degrees 
[3]. The third most prevalent component of articular cartilage, comprising approximately 30% of 
the dry weight is proteoglycans, which are made up of a number of sulfated glycosaminoglycans 
(GAGs) on a hyaluronic acid (HA) backbone [2]. The water, collagen, and proteoglycans 
together are referred to as the ECM of the tissue. Chondrocytes are responsible for producing and 
assembling the ECM components but only make up 2% of the volume of adult articular cartilage 
[4].  
There is a large amount of zonal variation in the composition and orientation of the ECM 
components of articular cartilage. Adult articular cartilage can be divided into four separate 
zones, i.e., the superficial zone, middle zone, deep zone, and calcified cartilage (Figure 2) [71]. 
The chondrocyte concentration is at its highest within the superficial zone [50], where the 
collagen fibrils run parallel to one another and the articular surface [71]. This collagen fibril 
arrangement gives the superficial zone the highest strength among the four zones [72], allowing 
the cartilage to withstand the mechanical forces (e.g. shear, compressive stress, tensile stress) 
experienced at the surface. In addition, while the concentration of aggregating proteoglycans is 
lowest in the superficial zone, smaller non-aggregating proteoglycans such as biglycan and 
decorin are most concentrated here[2]. 
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Figure 2. Zonal organization of hyaline cartilage, showing the superficial, middle, deep, and calcified 
cartilage zones. The dark lines represent the collagen fibrils which are thick and oriented vertically in the 
deep zone, randomly oriented in the middle zone, and oriented tangent to the surface in the superficial zone. 
The middle zone is rich in proteoglycans and contains larger collagen fibrils in a more 
random arrangement [50]. In the deep zone, the chondrocyte concentration is low and the 
proteoglycan (PG) concentration and collagen fibril diameter are at a maximum [50, 71]. The 
high collagen and PG concentration makes the deep zone the most resistant to compressive 
forces [73]. Next to the subchondral bone, the cartilage becomes mineralized, forming calcified 
cartilage, that has mechanical properties between the cartilage zones above and the bone below 
and which provides a good transition between the two [71]. 
2.2.3.2 Cartilage Responses to Mechanical Forces  
Two distinct mechanisms respond to the forces applied to cartilage: the resistance to 
interstitial fluid (water) flow through the ECM, and deformations of the ECM[74]. As 
mechanical forces are applied to the cartilage, a pressure gradient is generated in the interstitial 
fluid, causing fluid flow through the pores within the ECM. Because the pore size is small, fluid 
flow through them, referred to as the hydraulic permeability, is limited and therefore, causes 
significant flow resistance [75]. Moreover, the interaction between the negatively charged GAGs 
and the polar water molecules further limits fluid flow through the ECM pores [2]. This 
interaction combined with the hydraulic pressure gradient withstands as much as 95% of the 
mechanical force applied to the cartilage, the remaining 5% is achieved by ECM deformation 
[74]. This early fluid pressurization reduces the coefficient of friction between the articulating 
surfaces [76]. In healthy cartilage, the hydraulic permeability of the superficial zone is low and 
the pressures in the interstitial water in the deep and middle zones are relatively high [77]. These 
high internal pressures protect the ECM from most of the biomechanical loading. If these forces 
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are transmitted through the solid ECM, it may lead to cartilage degeneration [78], thus the 
variability of hydraulic permeability between patients may explain why some are more prone to 
joint diseases than others [79]. 
Interstitial water flow through the ECM gives rise to some time-dependent articular 
cartilage responses [80]. One of these is the displacement response of cartilage to a constant load 
applied over time, referred to as creep. For example, a creep response following an instantaneous 
elastic deformation may take approximately 1000 seconds to reach a new equilibrium state [80]. 
Another response is stress relaxation, which is the force response to a ramped displacement 
input. The cartilage requires time to react to the applied load or displacement and reach an 
equilibrium state (Figure 3). Notably, as the ECM deformation increases, the average ECM pore 
size decreases, which consequently increases the diffusional drag between the interstitial water 
and the ECM [81]. As a result, the time to reach the equilibrium state varies depending on the 
load/displacement applied. 
Figure 3. Time-dependent responses of cartilage to (a) a constant load and (b) a ramped displacement. The 
response in (a) is known as creep, and the response in (b) is stress relaxation.  
Measuring and characterizing the aforementioned time-dependent or transient responses 
of native cartilage or ECM, especially in an in-vivo environment, is both complex and difficult 
and the development of scientific instruments and tools for this purpose faces significant 
challenges. The mechanical properties of native cartilage or ECM have typically been measured 
once equilibrium is reached. The equilibrium or time-independent properties of cartilage or ECM 
include the aggregate modulus, Young’s modulus, shear modulus, and Poisson’s ratio [82], these 
are discussed in the following section, along with typical testing methods and procedures. To 
characterize the time-dependent responses or properties of cartilage or ECM, one promising 
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alternative to experimental measurements is the use of mathematical models, which are 
presented below in the mathematical modeling section. 
2.2.4 Mechanical Properties of Natural Cartilage and TECs and Testing Methods 
Three major methods for determining the mechanical properties of articular cartilage and 
TECs are tensile, compressive, and shear testing. Tensile testing is typically conducted either at 
equilibrium after a force is applied or at a constant strain rate. The compressive mechanical 
properties are often measured in three ways: confined compression, indentation, and unconfined 
compression, Shear properties are normally measured using either a constant displacement to 
find the equilibrium properties or a sinusoidal displacement to determine the dynamic properties. 
To find the tensile equilibrium modulus, a strip of cartilage is subjected to a stress 
relaxation test (Figure 4). This procedure subjects the sample to a stepwise series of 
displacements: at each displacement step, the stress in the cartilage is measured once it reaches 
its equilibrium value [83, 84]. The equilibrium stress at each step is then plotted as a function of 
strain, with the slope giving the tensile equilibrium modulus.  
In constant strain rate tensile testing, the sample is subjected to a constant strain rate and 
the tensile stress is measured at a certain sampling rate. The stress-strain plot of this test reveals a 
non-linear “toe-in” region where the collagen bundles are straightening out. Once the bundles are 
all straightened, the plot enters a near linear region that represents the stretching of these 
bundles: the data from this linear region can be used to calculate the tensile Young’s modulus 
[82, 84, 85]. Samples used in the tensile tests are typically cut in a dumbbell shape with a 
thickness of 200-300 µm, and strained at a rate of 5mm/min [84-88]. Depending on the 
specimen, the stress-strain curves obtained either at equilibrium or under a constant rate of strain 
may not be linear (Figure 5a), suggesting that the modulus is not a constant, but a function of 
strain or stress (Figure 5b) [88, 89]. 
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Figure 4. Schematic of the tensile testing apparatus, in which a TEC sample is submerged in a solution 
(usually phosphate buffered saline (PBS)) and subjected to either a tensile force or a tensile strain rate. Both 
strain and force (stress) are simultaneously measured and plotted against one another. 
Figure 5. Examples of tensile testing data for (a) a constant strain rate test (reprinted from [88] with 
permission from ASME) and (b) the relationship between equilibrium modulus and strain (reprinted from 
[89] with permission from Elsevier). In (b) the top line (triangles) represents adult, middle line (circles) 
represents adolescent, and bottom line (squares) represents young cartilage. 
Confined compression tests are typically pursued to measure properties such as the 
hydraulic permeability and the aggregate (equilibrium) modulus of cartilage samples outside of 
the body (ex vivo testing) [90-93]. Confined compression places a cylindrical cartilage sample 
into a tube-shaped container with an inner diameter that is ideally the same as the diameter of the 
sample, to prevent lateral expansion (Figure 6a) [82]. The test subjects the cartilage to a step load 
and measures displacement as a function of time (creep) (Figure 2a) or a short ramp 
displacement with stress measured as a function of time (stress-relaxation) (Figure 2b, Figure 
7a). The equilibrium displacement/stress is a function of the cartilage’s aggregate modulus[90]. 
The time it takes for the cartilage to reach the equilibrium displacement/stress is a function of its 
hydraulic permeability, aggregate modulus, and specimen thickness. A number of factors may 
TEC 
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affect the measured mechanical properties in these compression tests. First, the cartilage or TEC 
samples may not conform exactly to the inner diameter of the confined compression chamber, 
which results in an initial non-linearity [80, 91]. Next, the use of a porous piston can increase the 
tissue resistance during compression, which causes the measured material properties to be 
different from the true ones [80, 91]. The friction between the sample and the chamber has also 
been shown to affect measurements[94]. 
Figure 6. Schematic of types of compressive tests: (a) confined, (b) unconfined, and (c) indentation. Samples 
in confined compression are constrained on the sides. Unconfined samples are not constrained on the sides. 
Indentation uses a porous indenter to displace the cartilage, which is measured in situ. 
Figure 7. Examples of compression testing data: Data(a) stress-relaxation test of cartilage and (b) stress-
strain plot by using the confined, unconfined, and indentation testing methods (reprinted from [95] with 
permission from Elsevier). In (a) the top line is indentation, the middle line is confined, and the bottom line 
represents unconfined compression. 
Another commonly used compression test is indentation [82, 96, 97]. The indentation test 
(Figure 6c) is performed with the cartilage still attached to the bone (in situ), which suggests that 
this method has the potential to be used on living models. In this test, a porous indenter is used to 
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apply a step load to the cartilage and the displacement is measured as a function of time. An a 
priori model [97] is then used to fit the displacement vs. time data by using the non-linear least 
squares method. By doing so, parameters such as the aggregate modulus, hydraulic permeability, 
and Poisson’s ratio can be identified or estimated [82]. However, a number of assumptions in the 
indentation test may not reflect reality; the porous indenter may increase tissue resistance, 
cartilage permeability is not constant, and cartilage is not homogenous or isotropic. 
Prior to the biphasic theory developed by Mow et al. in 1980 [80], an elastic model was 
used for fitting the data obtained in the indentation tests [97] in which an approximation of the 
Poisson’s ratio was used to determine the aggregate modulus and hydraulic permeability. Later 
results from the use of biphasic theory show that the imperfection of Poisson’s ratio can result in 
data off by as much as 200% [97], suggesting that values of the aggregate modulus and hydraulic 
permeability from these earlier studies should be viewed with caution. 
Unconfined compression tests have not been as widely used as the indentation and 
confined compression tests [82]. In unconfined tests (Figure 6b), the cartilage is ideally 
compressed between two perfectly smooth, rigid, and impervious plates. However, this condition 
is nearly impossible, due to suction between the sample and the plates, that causes shear stress 
[98]. This suction effect can be reduced by applying a lubricant, such as synovial fluid, to the 
plates [95]. Similar to the other two types of compression tests, the sample is subjected to a step 
force, while the displacement is measured as a function of time. Hydraulic permeability can be 
measured and characterized similar to confined compression, with interstitial water flowing 
along the radial direction [98]. Once the sample reaches equilibrium, the compressive Young’s 
modulus and Poisson’s ratio of the ECM can be measured and determined [98]. 
In shear testing, a cylindrical sample of cartilage is subjected to a torsional displacement. 
For small torsional displacements, both the change in the sample volume and the pressure-driven 
fluid flow within the cartilage can be ignored, which allows for measurement of the viscoelastic 
properties of the ECM [99]. In the equilibrium shear test, the sample is subjected to a sudden 
constant displacement and the shear stress is allowed to reach an equilibrium value. Again, 
because of the lack of fluid flow, this equilibrium is reached much more quickly (10 s [82]) than 
in tensile and compressive tests (1000 s [80]). This test gives the normalized stress relaxation 
function, which is a ratio of the instantaneous shear stress to the initial shear stress at t = 0+: this 
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is used in the theory of quasilinear viscoelasticity, as described in the mathematical modeling 
section below, to determine the stresses present in the cartilage as a function of time for a given 
strain history [82, 100]. If the sample is subjected to a series of displacements, this test is used to 
determine the equilibrium shear modulus which is generally determined by calculating the slope 
of the equilibrium stress/strain plot (Figure 8a). While the stress-strain data are highly linear for 
shear strains of 0.03 and above, they may be better modelled by a quadratic relationship at lower 
values [101]. 
Figure 8. Plots showing (a) the dependence of equilibrium stress on strain in articular cartilage (reprinted 
from [101] with permission from Wiley) and, (b) the dependence of complex shear modulus and loss angle of 
alginate on forcing frequency (reprinted from [102] with permission from Wiley). 
The complex (dynamic) shear modulus characterizes the overall stiffness of the ECM 
under shear stress. This parameter can be measured by subjecting the sample to a sinusoidal 
strain small enough that fluid flow is not generated (0.00003 – 0.005) [99, 103, 104]. The 
complex shear modulus has a real portion (i.e., the storage modulus) and an imaginary portion 
(i.e., the loss modulus) (Figure 9) [99]. The storage modulus is in phase with the sinusoidal 
displacement and proportional to the amount of strain energy stored in the ECM. The loss 
modulus, on the other hand, is 90° out of phase with the displacement and proportional to the 
amount of strain energy dissipated in each cycle. The complex shear modulus is a more 
appropriate representation of the shear properties actually seen during dynamic activities such as 
running and walking [99]. Importantly, the complex shear modulus is a frequency-dependent 
measurement (Figure 8b), with values of the shear modulus typically reported for given 
frequencies in a range of 0.01-100 rad/s [102, 104, 105]. 
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Figure 9. Relationships among the storage modulus (G1), loss modulus (G2), complex shear modulus(G*), and 
loss angle (δ). The storage modulus represents the elastic portion of the modulus, while the loss modulus 
represents the modulus fraction due to viscous dissipation. 
The loss angle (Figure 9) describes how much of the complex modulus is due to the loss 
modulus and how much is due to the storage modulus. A loss angle of 90° would describe a 
completely viscous material, whereas a fully elastic material would have a loss angle of 0°. 
Materials mainly composed of collagen have a loss angle of about 3.6° [82], suggesting that 
collagen behaves in a very elastic manner. PG-rich materials, on the other hand, have a loss 
angle of approximately 70° [106], suggesting that the proteoglycans are largely responsible for 
the viscous portion of the complex shear modulus of cartilage. Articular cartilage has a loss angle 
of approximately 15°[81], suggesting that the elastic collagen network provides most of the shear 
stiffness of ECM. 
In the tests described above, choosing appropriate testing conditions such as the force and 
strain-rate applied to the sample, is critical, as is determining when the sample has reached 
equilibrium. These conditions and the equilibrium time will significantly affect the measured 
material properties [89]. In the literature, the equilibrium criteria are usually defined at specific 
times [101, 104] or stress-rates [95, 107], and thus vary from one study to another. It has been 
argued [89] that in most of the tests reported in the literature, equilibrium has not actually been 
achieved. Moreover, a higher strain rate can lead to a higher tensile modulus and an excessively 
large shear strain may drive fluid flow through the ECM, thus increasing the apparent shear 
modulii. Therefore, experimental designs based on these testing methods should bear the above 
in mind and involve a rigorous choice of test parameters. 
In addition, the type of test chosen may influence the properties measured. The 
indentation test yields a higher Young’s modulus than the confined and unconfined compression 
tests, possibly be due to the fibrous structure of the tissue being damaged from the sample 
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extraction process in confined/unconfined compression [95]. On the other hand, some material 
parameters, such as Poisson’s ratio appear to be independent of the test method used [108]. 
By means of the aforementioned methods, the mechanical properties of articular cartilage 
and TECs have been extensively investigated. Typical values of the measured mechanical 
properties are summarized in Table 3. For most entries, values are given within a range; this is 
due to the variation in the mechanical properties in different joint locations [97], donor species, 
and donor ages [84]. 
25 
 
Table 3. Summary of the mechanical properties of native articular cartilage and TECs as well as the tests 
used to ascertain each property (CC=Confined Compression, UC = Unconfined Compression, I = 
Indentation, TSR = Tensile Stress Relaxation, TCSR = Tensile Constant Strain Rate, ES = Equilibrium 
Shear, DS = Dynamic Shear). 
Mechanical 
Property Description Value Mechanical Test 
Native 
Cartilage TECs 
Aggregate modulus 
(MPa) 
Equilibrium compressive 
stiffness of cartilage 
constrained at the sides 
0.1-2.0 CC, I [74, 80, 108, 109] 
[51, 
110] 
Hydraulic 
permeability 
(m4/Ns) 
Ease by which interstitial 
water moves through the 
solid ECM 
10-16-10-15 CC, UC, I [1, 97]  
Compressive 
Young’s modulus 
(MPa) 
Equilibrium stiffness of 
cartilage unconstrained at 
the sides 
0.24-0.85 UC [74, 97, 108] [26] 
Poisson’s ratio 
Ratio of lateral strain to 
strain along the stress 
direction & a measure of 
the compressibility of pores 
in the ECM 
0.06-0.3 UC, I [51, 74, 108, 111] 
[51, 
110] 
Tensile Equilibrium 
Modulus (MPa) 
Tensile stiffness of cartilage 
at equilibrium, usually 
along the articular surface 
5-12 TSR [83]  
Tensile Young’s 
Modulus (MPa) –
constant-strain-rate 
Tensile stiffness of cartilage 
when subjected to a 
constant-strain-rate, usually 
along the articular surface  
5-25 TCSR [74, 84, 87]  
Tensile strength 
(MPa) 
Maximum amount of tensile 
stress endured by cartilage 
before rupturing, usually 
along the articular surface 
0.8-25 TCSR [72]  
Equilibrium shear 
modulus (MPa) 
Measure of the shear 
stiffness of solid ECM after 
all viscous ECM effects 
have subsided  
0.05-0.4 ES [101, 104]  
Complex shear 
modulus (MPa) 
Apparent stiffness of ECM 
which includes both viscous 
and elastic effects 
0.2-2.5 DS [82, 103, 104, 112]  
Shear loss angle 
(deg.) 
Measurement of how much 
of the complex shear 
modulus is due to viscous 
effects 
10-15 DS [51, 82, 104, 112]  
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Mechanical properties, such as the equilibrium shear modulus, Poisson’s ratio, and 
aggregate modulus vary significantly for different joint locations [82, 104, 111, 113]. Some 
recent research shows that mechanical properties even differ significantly between surfaces that 
articulate against one another [84]. This mechanical discrepancy between articulating surfaces 
may contribute to cartilage degradation [113]. Notably, some properties, such as the tensile 
Young’s modulus, are very sensitive to the anisotropies present in the cartilage. In one study 
[72], the tensile Young’s modulus depended not only on the zone from which the sample was 
taken from but also on the orientation of the sample. For example, a sample taken parallel to the 
split line1
2.2.5 Modeling of the Mechanical Properties of Cartilage and TECs 
 leads to a higher Young’s modulus than a sample taken perpendicular to the split line. 
Furthermore, a sample taken from the deep or middle zone has a lower tensile modulus than one 
from the superficial zone. In addition to joint location, orientation, and depth, donor species also 
affects the measured mechanical properties. An examination of cartilage samples from human, 
bovine, canine, monkey, and rabbit donors indicates the hydraulic permeability and Poisson’s 
ratio are significantly different, but the aggregate modulus is quite similar[114]. Finally, donor 
age will affect the measured properties, which tend to increase into adulthood, and then decrease 
with old age [72, 84, 85, 89, 90]. 
An emerging method that may provide an alternative to mechanical testing of cartilage 
tissue and TECs is mathematical modelling. The primary advantage of mathematical modelling 
over experimental methods in TEC design is their ability, once validated by experiments, to 
predict the behaviour of candidate TEC designs. This allows the optimum design to be identified 
without the need for extensive experimental investigations. Another unique advantage of 
mathematical models is that they can be developed and used to derive or estimate the mechanical 
properties of individual material phases within the cartilage based on the measured bulk 
behaviour. The progression of many diseases of cartilage results in the changes in mechanical 
properties [115]. As such, a sequential examination of this change can provide information on 
the progression of the disease and may lead to the identification of the primary mechanisms of 
                                                 
1 The split lines mentioned above are presumed to be indicators of the direction of the collagen fibres in the 
superficial layer[74] and can be determined by puncturing the cartilage with a circular awl. The resulting holes are 
“stretched out,” or elliptical, and the major axis of the ellipse is known as the split line direction[99]. 
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age-related cartilage degeneration. Experimental methods, however, only give the bulk or 
average properties of the cartilage, rather than the specific mechanical properties of local tissues. 
One possible experimental approach to this problem is the use of histology combined with 
micro- and even nano-indentation to measure the 3D distribution of mechanical properties in the 
tissue. However, in addition the problems of cutting-induced deformation from this approach, 
even nano-indentation may be unable to directly measure the properties of the individual phases 
within the cartilage tissue. Another way to estimate the properties of the individual phases within 
tissue would be to measure of the bulk properties of the tissue at specific locations, and then 
from these measurements derive the mechanical properties of each individual material phase 
within the tissue from a mathematical model.  
A TEC for cartilage repair is generally composed of three primary material phases: 1) a 
biodegradable framework or scaffold designed to persist briefly in the body before biological 
degradation; 2) cartilage tissue that has taken up residence inside the porous scaffold framework; 
and 3) fluid filled space. The mechanical properties of each of these individual phases and their 
volume fraction of within the TEC contribute to the effective mechanical behaviour of the three-
phase mixture. As an added complexity, the cartilage tissue component of this mixture is itself a 
complex composite material. A full theoretical treatment of the effective mechanical properties 
of TECs should first include the development of mechanical models for each of the constituent 
phases in the system. The resultant models should ideally represent the strain rate-dependent 
deformation of the phases in tension and compression for small and large deformations, and also 
include the time-dependent creep behaviour of the material phases of the TEC in tension and 
compression. These models are then applied in a homogenization scheme to give the effective 
properties of the mixture. 
The tissue scaffold component of the TEC is typically composed of synthetic 
biodegradable polymers that are either amorphous or semi-crystalline. The stress-strain 
behaviour of this kind of material under varying strain rates can be represented using models 
based on the networks of spring and damper elements (Figure 10) [116]. Based on such a model, 
the strain-rate-dependent behaviour of the polymeric scaffold material can be determined (Figure 
11).  
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Figure 10. Spring-dashpot networks representing resistance of the polymer to strain as an intermolecular 
resistance to deformation as well as resistance from molecular network reorientation (reprinted from [116] 
with permission from Elsevier). 
Figure 11. Stress-strain curves of polymers at different strain rates (reprinted from [116] with permission 
from Elsevier). 
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The next material phase in the TEC is the tissue cartilage itself. Many different 
approaches have been proposed to represent mathematically the behaviour of tissue cartilage. In 
one approach [117], the cartilage is modelled as a network of spring elements representing the 
fibrils pre-stressed by osmotic pressure. The Donnan osmotic pressure of the tissue is considered 
as a function of the tissue outer geometry, which can be altered to reflect its variation in a 
confined compression test. This model shows promise for reproducing the experimentally-
observed behaviour of cartilage at a specific strain rate. Further development or modification of 
these existing models to include the strain rate-dependency of the fibril network is urged. 
 Because cartilage shares similarities with moistened soil, poroelastic models developed 
for the analysis of soils offer another possible avenue for the modelling of cartilage tissue. In one 
approach [118], the poroelastic soil analysis elements present in the commercial software 
ABAQUS were employed to model the mechanical behaviour of a cartilage tissue plug in 
confined compression. The results obtained were compared to a mechanical model based on a 
biphasic rule of mixtures (detailed below) and close agreement was found. In another study 
[119], ABAQUS was employed to model cartilage tissue behaviour under compression, with 
agreement found between the experimental results and model predictions.  
Another model commonly employed to represent the load-deformation behaviour of 
cartilage is the biphasic model based on the rule of mixtures, which represents cartilage tissue as 
a linear elastic or non-linear visco-elastic matrix infused with an incompressible fluid phase. The 
governing equations for this model are the conservation of mass and momentum laws for a two 
phase liquid-solid mixture [120]. The conservation of mass for the solid fluid mixture is given by  
𝑑𝑖𝑣(?̇?) + 𝑑𝑖𝑣(?̇?) = 0             (2.1) 
where u is the displacement of the solid phase and w the displacement of the fluid phase with 
respect to the solid phase. The conservation of momentum for the two phase mixture is given by 
𝑑𝑖𝑣(𝝉) + 𝒇 = 𝜌𝑠𝑎𝑡?̈? + 𝜌𝑤?̈?         (2.2) 
where τ is the effective stress tensor of the mixture, f the body force vector, 𝜌𝑠𝑎𝑡 the density of 
the saturated solid, and 𝜌𝑤 the density of the fluid phase. Furthermore, the effective stress tensor 
τ can be decomposed into contributions from the solid and liquid phases 
30 
 
𝝉 = 𝝉𝒔 + 𝝉𝑤           (2.3) 
where 𝝉𝒔is the stress tensor for the solid phase and 𝝉𝑤 the stress tensor for the liquid phase of the 
tissue. In addition, the stress in the fluid phase can be represented as  
𝝉𝑤 = −𝜙𝑝𝑰           (2.4) 
where p is the pore pressure, 𝜙 the porosity of the tissue, and I the identity matrix. Furthermore, 
the velocity of the fluid phase with respect to the solid phase may be related to the acceleration 
of the solid phase by 
?̇? = −𝒌(𝑔𝑟𝑎𝑑(𝒑)
𝜌𝑤𝑔
) − 𝓰
𝑔
−
1
𝑔
𝒌?̈?         (2.5) 
where 𝒌 is the hydraulic conductivity (permeability) matrix of the solid phase 𝒑 the pore 
pressure distribution within the tissue, g the acceleration due to gravity, and 𝓰 the gravity 
acceleration vector. The above governing equations may be solved using the finite element 
method. After being placed into the finite element matrix form, a Newmark based numerical 
integration scheme can be employed [120] to solve the governing equations (2.3), (2.4), and (2.5) 
and estimate the nodal displacements of the solid phase and the nodal pore pressure distribution 
within the saturated solid body. While the above formulation assumes a linear elastic solid phase 
and an incompressible fluid phase with small deformations, this approach [120] also results in a 
large deformation finite element formulation for the conservation of mass and momentum when 
the solid phase is assumed to be compressible and hyperelastic. A further development is the 
triphasic model of cartilage, which divides the liquid phase further into two separate fluids, i.e., 
intrafibrillar and extrafibrillar fluid phases. The intrafibrillar fluid phase contains intrafibrillar 
water, sodium ions, and chloride ions; the extrafibrillar fluid phase includes proteoglycans, 
extrafibrillar water, and sodium and chloride ions[121]. This model gave predictions in 
agreement with experimental results from confined compression tests [121].  
 Another approach [122] presents a generalized n+2 phase theory for charged hydrated 
tissue. The charged and hydrated tissue is modelled as a continuum of three phases, i.e., solid 
phase, solvent phase, and n ion phases or species dissolved in the solvent. The solid phase and 
ions are assumed to carry charge, while the solvent phase is neutral. The continuity equation for 
such a system is given by 
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𝑑𝑖𝑣(?̇?𝑠) + 𝑑𝑖𝑣[∑ 𝜙𝛼(?̇?𝛼 − ?̇?𝑠)] = 0𝛼        (2.6) 
where ?̇?𝑠 is the velocity of the solid, ?̇?𝛼 the velocity of constituent α, and 𝜙𝛼 the volume 
fraction of constituent α. The momentum equation is given in terms of electrochemical potentials 
for the solvent and ions in the n+2 phase mixture, i.e.,  
−𝜌𝛼∇𝝁�𝛼 + ∑ 𝒇𝛼𝛽(?̇?𝛽𝛽 − ?̇?𝛼) = 0        (2.7) 
where 𝜌 is the density of each phase, 𝝁�𝛼(J/kg) the electrochemical potential of each constituent, 
and 𝒇𝛼𝛽 the friction force between the various constituents in the mixture. These equations can 
be cast into their weak forms and integrated over the entire volume of the considered tissue 
sample, where the unknown parameters in the finite element implementation are the 
displacements of the n+2 constituents. Alternatively, the governing equations can be solved with 
a forward difference numerical method [122]. 
Another mathematical model developed to represent the constitutive behaviour of 
cartilage tissue in both tension and compression is based on the theory of quasilinear 
viscoelasticity (QLV) proposed by Fung [100]. This model represents tissue as a homogenous 
rheological fluid, where the stress in the body with time 𝜎(𝑡) is given as function of the stretch 
ratio 𝜆(𝑡) [123], 
𝜎(𝜆(𝑡); 𝑡) = ∫ 𝐺(𝑡)𝑇𝑒(𝜆)𝑑𝑡∞0        (2.8) 
where 𝑇𝑒(𝜆) is elastic stress as a function of the stretch ratio and 𝐺(𝑡) the ratio of current stress 
to the elastic instantaneous stress present immediately after load application, which is given by 
𝐺(𝑡) = 𝜎(𝑡)
𝜎(𝑡=0)          (2.9) 
The stress response of the system to an infinitesimal change in stretch when the object is initially 
in the state of stretch 𝜆 at the time 𝜏 is given by 
𝛿𝜎(𝑡) = 𝐺(𝑡 − 𝜏) 𝜕𝑇𝑒(𝜆(𝜏))
𝜕𝜆
𝛿𝜆(𝑡)       (2.10) 
where 𝜎(𝑡)is the first Piola-Kirchhoff stress as a function of time, which is evaluated from the 
forces in the deformed configuration of a body and the areas present in the original reference 
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configuration of the body. The stress history in the body with time is given by the time integral 
of Equation (2.10), i.e.,  
𝜎(𝑡) = ∫ 𝐺(𝑡 − 𝜏) 𝜕𝑇𝑒(𝜆(𝜏))
𝜕𝜆
𝜕𝜆(𝜏)
𝜕𝜏
𝑡
−∞
𝑑𝜏 = 𝑆𝑒(𝑡) − ∫ 𝜕𝐺(𝑡−𝜏)
𝜕𝑡
𝑆𝑒(𝜏)𝑡
0
𝑑𝜏  (2.11) 
where 𝑆𝑒 is the stress from the instantaneous nonlinear equilibrium response of the tissue, 𝐺 the 
reduced relaxation function, 𝜕𝑇
𝑒(𝜆(𝜏))
𝜕𝜆
 the instantaneous elastic response to an infinitesimal 
change in the stretch ratio, and 𝜕𝜆(𝜏)
𝜕𝜏
 the strain history. Once the mechanical property functions in 
the model 𝐺(𝑡) and 𝑆𝑒(𝑡) are known, the time-dependent stress 𝜎(𝑡) can be determined for a 
known strain history. For the tensile response of cartilage, the following stress relaxation 
function is proposed [124], 
𝐺 = 1 + 𝛼
1+�
𝑡
𝜏
�
𝛽        (2.12) 
where 𝛼, 𝑡, and 𝜏 are the material property parameters that can be estimated from a stress 
relaxation test [124]. The instantaneous stress relaxation of the tissue in compression or tension 
is experimentally determined, typically taking the form of  
𝑆𝑒(𝜺) = 𝐸(𝜺)𝜺       (2.13) 
where 𝜺 is strain (stretch ratio) and 𝐸(𝜺) a non-linear function for compressive and tensile 
loading determined from the initial behaviour of a tissue sample under compression or tension. 
The above model was used to represent the tensile response of cartilage tissue, dominated by the 
viscoelastic behaviour of the cartilage solid matrix [124]. Under compression, the viscoelasticity 
of the tissue is fluid-flow dependent and is modelled by using a relaxation function to account for 
the effect of fluid flow on the cartilage. Because this modelling method represents the cartilage 
as a homogeneous solid, the resultant QLV model cannot represent the material properties of 
individual constituents within cartilage. If a TEC is considered, however, this method would be 
used to estimate the mechanical properties of the regenerating tissue within the scaffold from the 
measurements of the effective properties of the TEC. This is an inverse problem, where the 
known effective properties of the TEC are functions of the unknown properties of its 
constituents. The QLV model can be incorporated into biphasic theory to give a more accurate 
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representation of the behaviour of the cartilage matrix, which is assumed in classical biphasic 
theory to be only a simple linear elastic material [125]. 
With the availability of models for both the cartilage tissue and solid scaffold material 
phases, the next step in modelling the TEC’s effective mechanical properties is to combine the 
material models based on the homogenization method. Considering a representative piece of the 
TEC, with strain-dependent stress strain curves for each material phase, finite element models of 
the TEC can be constructed and subjected to displacement boundary conditions that simulate the 
effect of a mechanical test. For cases with large displacements, non-linear material behaviour, 
and/or strain rate dependence, the non-linear problem can be linearized by applying the 
prescribed displacement boundary conditions as step loads and/or updating the modulus of 
material at the experienced strain level in each of the finite elements. During each step, the 
configuration of the nodes from the previous step is employed to assemble a linear stiffness 
matrix, and the strain in each element, determined in the previous load step, is employed to select 
an appropriate stiffness for each element in the body from the known stress-strain curves of the 
constituents. This approach may be executed using commercial software, such as ANSYS. 
Unfortunately, representation of the full TEC in a finite element model is a significant 
computational burden. An alternative is the use of a small representative piece of the TEC, which 
is known as a representative volume (RV). This is accomplished based on the homogenization 
method, in which a TEC is represented by a finite number of RVs that possess location-
independent mechanical properties. A type of traction or deflection boundary condition is then 
applied to the RV such that the average stress within the body is an average of the stress 
distribution experienced by all of the assembled cells in the complete TEC. To effectively 
represent RV deformation in the presence of neighbouring cells, the deformation pattern of the 
RV’s outer surface should be some type of average of the deformation shape experienced by all 
the unit cells in the TEC. One deflection boundary condition to achieve this objective is the 
periodic deflection boundary condition, where the displacements on opposite sides of the RV tile 
together. These displacement boundary conditions are represented mathematically as [126] 
𝑢𝑖 = ?̅?𝑖𝑗𝑥𝑗 + 𝑣𝑖        (2.14) 
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where 𝑢𝑖 is the displacement of a node on the boundary of the RV, ?̅?𝑖𝑗 the average strain 
experienced in the RV, 𝑥𝑗 the location of the boundary node, 𝑣𝑖 the periodic component of the 
boundary node displacement, and 𝑖, 𝑗 = 1,2,3 indices indicating global coordinate directions. For 
a square RV, the above expression becomes 
𝑢𝑖
𝐾+ = ?̅?𝑖𝑗𝑥𝑗𝐾+ + 𝑣𝑖𝐾+, 𝑢𝑖𝐾− = ?̅?𝑖𝑗𝑥𝑗𝐾− + 𝑣𝑖𝐾−    (2.15) 
where 𝐾 + indicates the positive 𝑥𝑗 direction and 𝐾 − the negative 𝑥𝑗 direction. The difference 
between the deflections on opposite sides of the RV is therefore given by 
𝑢𝑖
𝐾+ − 𝑢𝑖
𝐾− = ?̅?𝑖𝑗(𝑥𝑗𝐾+ + 𝑥𝑗𝐾−)      (2.16) 
If the TEC considered is heterogeneous, the strategy of using averaged properties can be applied 
and expressed mathematically by  
𝑆?̅?𝑗 = 1𝑉𝑅𝑉 ∫ 𝑆𝑖𝑗𝑑𝑉 𝑉𝑅𝑉 , 𝑇�𝑖𝑗 = 1𝑉𝑅𝑉 ∫ 𝑇𝑖𝑗𝑑𝑉 𝑉𝑅𝑉      (2.17) 
where 𝑆𝑖𝑗 𝑇𝑖𝑗 are the strain and stress, respectively, and the over-bar indicates a volume average.  
Representing or modelling the displacement-under-loading behaviour of hydrated tissues 
such as cartilage by solving the governing equations in the above shows promise. Constitutive 
relations for all of the material phases within the TEC can be incorporated into finite element 
models of the TEC to predict its mechanical behaviour. The primary source of error in such 
models is considered to mainly come from the assumption of homogenization in each structural 
level of the TEC. With the advance of computing technologies, future work should include more 
structural details in finite element models of the TEC to release or partially release the 
homogenization assumption of the TEC structure. 
2.2.6 Methods to Enhance the Mechanical Properties of TECs 
The mechanical properties of TECs for cartilage repair should match those of native 
articular cartilage. As discussed above, the mechanical properties of cartilage vary widely and 
depend on donor species and age, as well as joint location and sample orientation. As such, the 
mechanical properties of TECs should be defined and determined differently for specific 
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implantation sites. To make things more challenging, the TEC’s mechanical properties are not 
constant during the healing process, but change dynamically with time as the tissue regenerates 
and the scaffold degrades. Thus, engineering functional cartilage with matching mechanical 
properties has proven to be extremely difficult and, so far, engineered cartilage has largely been 
mechanically inferior to native cartilage [105, 127-129]. A number of methods or techniques 
have been developed to enhance the mechanical properties of engineered cartilage, including 
control over the amount of ECM components that the chondrocytes produce, control over the 
fibre geometry within the scaffolds, and selection of scaffold materials with appropriate 
mechanical properties. 
By modifying the amount of ECM components, i.e, proteoglycans and collagen, that the 
chondrocytes produce, the mechanical properties of the cartilage can be controlled. For example, 
the shear storage and tensile modulus can be enhanced by increasing collagen concentrations or 
the cross-linking of the collagen fibrils [99, 130]. On the other hand, decreasing the PG 
concentrations within the ECM can reduce the tensile and compressive moduli by 10-fold[82, 
99]. One method for controlling collagen and proteoglycan levels within the ECM is the use of 
mechanical stimulation, such as hydrostatic pressure [131] and dynamic shear or 
compression[132]. The levels of PG and collagen vary, depending on the type of loading 
regimen [131], for example, if the loading frequency is low (0.3 Hz) or high (3 Hz), ECM 
production can be inhibited, with 1 Hz appearing optimal for ECM production [34, 107, 133]. 
The compression amplitude can also regulate both PG and collagen synthesis [107]. These 
findings have been recently applied to bioreactor design, so that they are able to mimic the 
dynamic forces seen in the native joints and thereby create cartilage with similar mechanical 
properties [134]. By altering the flow conditions within the bioreactor one can adjust the 
mechanical properties and possibly improve the mechanical properties of TECs [92, 129]. In the 
aforementioned processes, the interactions between cells and ECM play a critical role. These 
interactions, however, are complicated and many remain to be defined. In addition to 
experimental methods, the use of finite element methods would be a powerful tool to discover 
links between mechanical stimulation and cellular activity [135]. 
Another method of adjusting the levels of proteoglycans and collagens is the use of 
chemical stimulants, the most common of which is fetal bovine serum (FBS). FBS is a clear fluid 
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fraction prepared from clotted blood that contains various hormones, growth factors, and other 
bioactive stimulants. When added to cell culture, FBS increases cell proliferation and ECM 
production [136]. However, one large drawback is that this serum has a poorly defined 
composition, which can lead to problems with growing tissue in a repeatable manner [137]. 
Recent studies have used other individual stimulants, such as bone morphogenetic proteins and 
transforming growth factors [14, 15, 17-19], that have a more defined composition and give 
more repeatable results. In addition, natural cartilage ECM components such as HA and 
chondroitin sulphate (CS) can mechanically enhance TECs. The addition of HA to a cell medium 
or hydrogel enhances the production of GAG and collagen II as well as significantly increases 
cell proliferation [21, 22]; the addition of CS increases cell proliferation and PG synthesis [23, 
24]. However, these individual stimulants are relatively costly and have problems including 
retention them within the TECs [43]. 
The mechanical properties of TECs can also be controlled via the design of scaffolds for 
the repair of cartilage. Increasing scaffold porosity would increase the loss angle and plastic 
deformation and decreases the storage modulus and aggregate modulus [51]. Changing the strand 
orientation within the scaffold, for example from a 0-90 to a 0-45 pattern (Figure 12), or using 
different types of honeycomb structures can significantly alter the mechanical properties [51, 
138]. Another important consideration is the biological properties of the scaffold. Pore size 
cannot be made arbitrarily small for maximizing the aggregate modulus because a certain pore 
size and porosity is necessary to allow for cell delivery and tissue ingrowth. Mathematical 
models may allow one to optimize the trade-off between tissue growth and porosity before even 
entering the laboratory [139]. 
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Figure 12. Schematic showing the strand orientation for the 0-90 (a) and 0-45 (b) solid scaffold geometries. 
Different scaffold materials are recognized as having different mechanical and biological 
properties. These distinct yet diverse properties can be used to control and ensure the mechanical 
properties of the TEC. For example, a scaffold made out of poly(glycolic acid) (PGA) is stiffer 
than one with an identical geometry made of poly(lactic acid) [56]. Different materials also 
differentially stimulate chondrocytes. For example, a PGA scaffold stimulates PG synthesis 
while a collagen scaffold stimulates collagen II synthesis [140]. Further developments or 
investigations are urged to strategically combine different materials in scaffold designs to 
achieve synergistic properties of scaffolds.  
2.2.7 Future Research Work 
An initial goal of cartilage tissue engineering was to create a homogeneous tissue with 
the same bulk properties as the surrounding tissue [141]. However, current research has focused 
on creating mechanical property gradients within the TECs to more closely mimic the four zones 
found in native cartilage. The potential for stratification has been demonstrated through the 
creation of pore size, porosity, and stiffness gradients[50] within fabricated scaffolds. Recently, 
layered TECs were shown to reduce strain discontinuities between the TEC and the surrounding 
natural cartilage [27], demonstrating their promise for achieving mechanical property gradients 
within TECs. Hydrogels are well known for their biocompatibility and recently have been 
demonstrated as suitable for creating such layered scaffolds. Moreover, chondrocytes can be 
isolated from the different zones of native cartilage and cultured separately. These different cells 
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can then be encapsulated in separate hydrogel disks. Eventually, these disks can be layered on 
top of one another to produce a stratified culture [25], with the construct producing a smooth 
transition between the layers with time [142]. These constructs also have the potential to create 
layers with differing chemical stimulants and/or mechanical properties. One promising research 
avenue for the creation of stratified TECs is the development of a hybrid scaffold that 
incorporates the “cell friendly” environment of a hydrogel with the mechanical stability of a 
solid polymer scaffold. Control of the mechanical properties of these scaffolds would be easier 
than with hydrogels alone, and includes the opportunity to create different hydrogel layers (as 
discussed above) within the solid scaffold. Preliminary studies of these hybrid scaffolds have 
shown promising results[39]. More experiments will be needed with different types of cell 
stimulation and scaffold design before TECs are created with the desired bulk and local 
mechanical properties of natural articular cartilage.  
To design TECs with the desired mechanical properties gradients, an alternative method 
to the experimental methods is the use of mathematical models. Mathematical models, including 
one based on modeling updating [143], have been developed to predict the time-dependent 
mechanical properties. Some mathematical models of the behaviour of cartilage tissue give good 
predictions of experimental tissue behaviour. The last component necessary for the complete 
mathematical analysis of cartilage TEC mechanical properties and their time dependent 
evolution is a model that can describe the time-dependent regeneration and behaviour of tissue 
within the TEC [144]. If such models can be improved to more accurately represent the strain-
dependent mechanical properties of tissue/scaffold under compression and tension, and the 
gradual change in tissue/scaffold composition during scaffold degradation and tissue 
regeneration, they will provide an effective means to mathematically evaluate TEC designs and 
optimize their performance. This will require determining or modelling various interrelationships 
within the scaffold, such as the effects of living tissue and scaffold degradation products on the 
degradation rate of the solid scaffold. 
As cartilage tissue engineering moves towards implanting TECs to repair damaged 
cartilage in human patients, non-invasive methods of testing the properties of the implanted 
TECs in situ must be developed. The only one of the aforementioned methods currently capable 
of testing implanted TECs in situ is indentation, and even this method would require surgery. In 
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order to track the properties of TECs after implantation, imaging methods such as magnetic 
resonance imaging [79] show the most promise. Typically, image-based methods are based on 
the idea of measuring the strain in the cartilage before and after loading in a joint and using these 
measurements to determine the aforementioned mechanical properties. These imaging methods 
will help researchers determine the success of TEC implants without subjecting the patient to 
another surgery. 
2.2.8 Conclusions 
Cartilage tissue engineering has made great strides towards growing cartilage substitutes 
with the mechanical properties necessary to withstand the loads found within joints. 
Mathematical modeling, in conjunction with tensile, compressive, and shear testing, provides 
researchers with the mechanical properties that govern both the equilibrium and the transient 
responses, and allows the accurate comparison of TECs to natural cartilage accurately. 
Although current TECs have, for the most part, not achieved mechanical properties that 
match those of natural cartilage, considerable progress has been made in the development of 
methods to modify the mechanical properties of TECs. These methods include modifying the 
amount of ECM components produced by chondrocytes through mechanical or chemical 
stimulation, adjusting the internal scaffold structure, and choosing appropriate scaffold materials 
or their combinations. Further work or development to create stratified cartilage and 
mathematically model the time-dependent properties of TECs is encouraged to achieve 
mechanical property gradients within the TECs to mimic the four zones found in native cartilage.  
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Chapter 3: Materials and Methods 
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3.1 Introduction 
This chapter outlines the methodology used in pursuit of the objectives outlined in 
Section 1.3. After fabrication, the solid scaffolds were photographed and then examined using 
microtomography to determine porosity, pore size, and to confirm that the pores were 
interconnected throughout the scaffolds. In addition, the Hoechst assay was used to determine 
cell population on disks of the scaffold material after a week of culture. 
To determine the effects of hyaluronic acid (HA) and chondroitin sulphate (CS) on 
chondrocytes in hydrogel culture a number of tests were used to examine cell proliferation and 
matrix production. The 1,9-Dimethylmethylene Blue (DMMB) assay and immunostaining were 
used to examine ECM production, while the Hoechst DNA assay was used to quantify cell 
proliferation. Finally, Real-Time Quantitative Polymerase Chain Reaction (qPCR) was used to 
show concentration of the mRNA that encodes for aggrecan and collagen types I and II relative 
to GAPDH. 
To examine the differences in cell population between the composite scaffold and solid 
scaffold controls the Hoechst DNA assay was used, while the differences in matrix production 
were elucidated using the DMMB assay. The preceding information is summarized in Figure 13. 
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Figure 13. Flow chart summarizing the majority of the experimental work done in the present study. The 
brown entries represent the sample information, the blue entries represent the experimental test performed 
on said samples, and the yellow entries represent the final goal of the experimental tests. The ultimate goal of 
the study, as denoted by the thick arrows, was the fabrication and characterization of the solid/hydrogel 
scaffolds. 
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3.2 Solid Scaffold Fabrication and Characterization 
3.2.1 Fabrication of Solid Scaffolds and Substrates 
3D scaffolds were fabricated for the purpose of characterizing pore size and porosity and 
to ensure that overhanging structures existed throughout. 2.0 g of PLGA (50:50 copolymer of 
polylactic and polyglycolic acid; Lactel, CA) were dissolved in 5.0 ml of chloroform to make a 
40 % (w/v) solution, and 3.0 ml of the PLGA-chloroform solution were then mixed with 1.2 g of 
iron(III) oxide (IO) powder (<50nm particle size, Sigma) and stirred thoroughly. This material 
slurry was then loaded into a 10 ml syringe and hooked up to a rapid-prototyping (RP) machine 
(C0720M, Asymtek, Figure 14). The programmed initial dimensions of each scaffold were 5.25 
mm x 5.25 mm x 2.5 mm with a horizontal pore size and strand diameter of 250 µm, as shown in 
Figure 15. After deposition, scaffolds were placed in a fume hood overnight to allow the 
chloroform to evaporate and the scaffolds to harden. Some shrinking of the scaffolds occurred 
during this period. 
Figure 14. RP machine used to fabricate the initial scaffolds which were utilized for the purposes of scaffold 
characterization using microtomography. The material slurry is dispensed through a needle as the moving 
head that the syringe is attached to moves along a pre-programmed path. Layers were sequentially deposited 
on top of one another to create the 3D construct. 
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Figure 15. Schematic of the solid scaffolds showing top (left) and side (right) views with all dimensions in 
millimetres and the ϕ representing a diameter. The horizontal pore size and strand diameter were both 0.25 
mm. 
In some experiments, flattened discs of the above scaffold material were fabricated for 
the purpose of determining the material’s ability to support chondrocyte culture. These discs 
were much easier to fabricate than the solid scaffolds, as they used a mould rather than a RP 
machine, which allowed for a larger number of samples in these experiments. The material slurry 
for these discs was comprised of 700 mg of either hydroxyapatite (HAP) or IO that was mixed 
with 3.0 ml of a 23.3% solution of PLGA in chloroform. The additional chloroform lowered the 
viscosity of the slurry, allowing it to be poured into a plastic mould, forming a 1 mm thick film 
without pores. After the chloroform evaporated, the final ratio of PLGA to iron oxide was the 
same as in the slurry used to fabricate the 3D scaffolds, and 5.0 mm discs were cut using a 
dermal biopsy punch. 
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3.2.2 Scaffold Characterization 
After the scaffolds were fabricated it was necessary to confirm their final porosity, 
average pore size, and that the pores were indeed connected to one another throughout the 
construct. Photographs of the solid scaffolds were taken using a dissection microscope (Wild, 
Heerbrugg) to visually confirm that overhanging structures (i.e. interconnected pores) were 
present on the exterior of the scaffold. In addition, microtomography imaging was performed 
(Skyscan 1172 micro-CT instrument, Kontich, Belgium) on four of the scaffolds to determine 
average pore size, porosity, and strand diameter, as well as the internal structure of the scaffolds. 
Images were taken at an energy of 55 keV, with a 460 ms exposure and 0.5 mm Al filter used. 
The voxel size was 10 µm and an angular step of 0.21° was used. The resultant tomography data 
was analysed using CT-Analyser software (Skyscan). 
3.2.3 Cell Culture 
To demonstrate the biocompatibility of this scaffold material, primary chondrocytes were 
cultured on it in vitro for one week. Articular cartilage was harvested from the femoral and 
humeral heads, lateral and medial condyles, and patellae of newborn pigs. These piglets were 
obtained from the Prairie Swine Centre, and had died spontaneously no more than 24 hours prior 
to dissection. The cartilage was minced into 1-2 mm fragments using scalpels and subjected to a 
sequential digestion in which the tissue was incubated for 1 hour (37ºC, 5% CO2, 100% RH) 
with 10 mg/ml pronase (Boehringer) in Dulbecco’s Modified Eagle Medium (DMEM; Sigma) 
supplemented with GAK (0.292 mg/ml glutamine; 100 U/ml penicillin; 100 µg/ml streptomycin, 
0.25 µg/ml amphotericin B, 100 µg/ml kanamycin), and then treated with 2 mg/ml collagenase 
(Type IA; Sigma) in DMEM supplemented with 10% Fetal Bovine Serum (FBS) and GAK and  
for 4 hr with intermittent agitation. The resulting digest was then passed through a 100 µm Nitex 
filter and the isolated chondrocytes were isolated by centrifugation (10 min, 300g) and 
resuspended in DMEM/10%FBS/GAK. 
Both the PLGA-HAP (n=16) and PLGA-IO (n=16) substrate discs were sterilized in 95% 
ethanol for 15 minutes, rinsed twice with Hanks’s saline[145], and placed in a sterile 96-well 
tissue culture plate. For each type of substrate, 8 discs and 8 empty culture wells were seeded at a 
density of 1.75x106 cells/cm2 in DMEM/10%FBS/GAK. The remaining 8 discs and 8 additional 
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empty wells were not seeded with cells and had an equal amount of DMEM/10%FBS/GAK 
medium added to serve as a no-seed control. Seeded wells and no-seed controls were incubated 
for seven days with a medium change on day 4. 
3.2.4 Hoechst DNA Assay 
The Hoechst DNA assay uses a fluorescent dye that binds to DNA for the purposes of 
determining cell population (i.e. DNA concentration) within a sample. 
After culture, all wells were rinsed with Hanks’s saline and the substrates were removed 
and individually placed in a sterile 96-well plate. To account for the difference in culture surface 
area, 150 µl of 1.25 mg/ml trypsin in calcium and magnesium free Puck’s saline[146] was added 
to each well containing a 5.0 mm substrate disc, whereas 216 µl of trypsin solution was added to 
each 6.0 mm empty well containing no substrate. Cultures were incubated for 10 minutes (37ºC, 
5% CO2, 100% RH) in the trypsin solution and the cells were dislodged by pipetting up and 
down, after which the cell suspensions were put in microtubes and frozen at -20ºC. Samples were 
later subjected a fluorometric DNA assay similar following a modification of the method of 
Labarca et al[147]. Briefly, samples were thawed and sonicated, then a 70 µl aliquot of each 
sample was mixed with 30 µl of 4 µg/ml Hoechst 33258 dye (Sigma), and 100 µl of 2X buffer 
(0.1 M NaH2PO4, 4 M NaCl, pH 7.4). Samples were then loaded into a black-plastic 96-well 
microtiter plate and read on a plate-reader fluorometer (Fluorolite 1000, Dynex) at an excitation 
wavelength of 365 nm and an emission wavelength of 458 nm. Samples were run alongside a set 
of DNA standards (0 - 4 µg/100µl chicken DNA, Sigma) for absolute quantification of DNA in 
each unknown sample. 
3.2.5 Statistics 
An analysis of variance combined with a Tukey’s Honest Significant Differences post-
hoc test was performed using R© (version 2.10.1)[148] to test for significant differences between 
treatment groups in the Hoechst assay. A p value less than 0.05 was considered to be significant. 
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3.3 Hydrogel Preparation and Characterization 
This experiment had both a preliminary pilot study and a later full experiment 
component. Both experiments had similar hydrogel preparation protocols and mainly differed in 
their sample sizes, RNA extraction techniques, and time points. The main purpose of the 
preliminary pilot study was to ensure that the proposed methodology would work in the full 
experiment. However, this pilot study ended up providing some useful data and as such, is 
included within this thesis. 
3.3.1 Fabrication of Supplemented Hydrogels for Full Experiment 
Chondrocytes were isolated according to the procedure outlined in Section 3.2.3. Fibrin-
alginate hydrogels were created using a protocol similar to those described previously[42, 149]. 
Briefly, solutions of 62.5 mg/ml of fibrinogen (Sigma) and 30 mg/ml alginate (Sigma) were filter 
sterilized using syringe filters specifically designed for viscous solutions (glass prefilter to 0.2 
µm; Filtropur, Sarstedt, catalogue # 83.1826.102). The solutions of 102 mM CaCl2 and 100 U/ml 
of thrombin were filter sterilized using conventional 0.2 µm syringe filters. 
The alginate was supplemented with enough HA and/or CS for a final concentration of 
0.1 mg/ml of each/either macromolecule in the final hydrogel. The alginate, fibrinogen and cell 
suspension (5x107 cells/ml) were mixed together in a 1.5 ml tube, and then the thrombin was 
added to cleave the fibrinogen into fibrin. The final concentrations of the gel components were 
25 mg/ml fibrinogen, 12 mg/ml alginate, 5x106 cells/ml, and 10 U/ml thrombin with each gel 
being 196 µl in total volume. The gel mixture was incubated at 37°C for 15 minutes to allow the 
fibrin portion of the gel to set. Then, 588 µl of CaCl2 were added to the microtube and the 
mixture was incubated for an additional 20 minutes to crosslink the alginate. After crosslinking, 
the gels were moved to 12 well tissue culture plates (2.1 cm diameter each) containing 
DMEM/10% FBS/GAK supplemented with 0.1 mg/ml HA alone, 0.1 mg/ml CS alone, both HA 
and CS (HACS), or neither additive. 
This was a factorial experiment with one set of samples (n=8 for each treatment) 
harvested at week 1, another harvested (n=6 for each treatment) at week 2, and 5 untreated 
samples being harvested immediately. Some samples (n=7 for week 1; n=5 for week 2 for each 
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of the four treatment groups) were used for biochemical analysis of total sulphated GAG content. 
The hydrogel samples were rinsed in Hank’s saline for 10 minutes, after which they were 
incubated at 37ºC with 471 µl of hydrogel dissolution solution (90 mM NaCl, 55 mM sodium 
citrate, 30 mM EDTA, 0.1 mM Tris HCl, pH 7.5, 0.2mM CaCl2, 0.2 mg/ml proteinase K 
(Invitrogen Life Technologies)) until the gels were completely dissolved. A 30.4 µl aliquot of 
this digest was removed and mixed with 70.6 µl triple-distilled water, then stored at 4°C for later 
use in the DMMB assay for GAG quantification. The remaining hydrogel digest was centrifuged 
(5 minutes, 4°C, 300 g), the supernatant was removed and the pelleted cells were resuspended in 
110 µl of Hank’s saline. A 10 µl aliquot of this cell suspension was mixed with 160 µl of Hank’s 
saline and frozen for the Hoechst DNA quantification assay. For the week 1 samples, the 
remaining 100 µl of cell suspension was mixed with 300 µl of TRIzol® LS reagent (Invitrogen 
Life Technologies). The cells were then immediately lysed by repeated aspiration through a 27-
gauge syringe needle and frozen at -80°C for later RNA analysis. 
3.3.1.1 Fabrication of Hydrogels for Preliminary Pilot Experiment 
A preliminary experiment performed earlier was almost the same that outlined above 
with a few notable exceptions. The hydrogel dissolution solution contained 10 mg/ml trypsin 
instead of proteinase K. The isolated cells were also lysed and stored in GTC lysis buffer 
(Omega Bio-Tek) rather than the TRIzol® LS. Attempts to isolate RNA from the preliminary 
pilot experiment were unsuccessful, leading to the development of the above protocol which 
used TRIzol® LS and proteinase K and better protected the RNA from degradation. The cell 
pellet was resuspended in 1 ml of Hank’s saline and a 40 µl aliquot of this suspension was 
diluted in 110 µl of Hank’s for the Hoechst assay samples. In addition, the sample size was much 
smaller (n=3 plus one sample for cryogenic sectioning, for each treatment) and there was only a 
single time point which was harvested at 10 days. 
3.3.2 DMMB assay 
The DMMB assay used for sulphated GAG analysis was adapted from a combination of 
several protocols found in the literature [21, 31, 32, 150] and modified for use with alginate by 
adjusting the pH of the dye to 1.5, which effectively protonates the alginate which would 
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otherwise compete with the GAGs for binding sites on the DMMB dye molecules[150]. Briefly, 
21 mg of DMMB (Sigma) was dissolved in 5 ml absolute ethanol. Then 2 g of sodium formate 
was added, and this solution was mixed with 800 ml of triple-distilled water. Formic acid (95%, 
Sigma) was added to the solution until the pH was 1.5 and then triple-distilled water was added 
until the final volume was 1 L. A buffer solution lacking DMMB dye was also prepared in an 
identical manner. In addition, a set of GAG standards was created by mixing seeded hydrogels 
(as in Section 3.3.1) supplemented with known amounts of CS (0 – 100 µg/ml final 
concentration). 
For the full experiment samples harvested after one week (week 1) samples, the DMMB 
dye solution was diluted with an equal part of buffer to increase the sensitivity of the assay. A 48 
µl aliquot of the diluted hydrogel digests (both samples and standards) was added to 300 µl of 
the diluted DMMB dye, and then incubated at room temperature for 1 hour. Thereafter, the 
samples and standards were centrifuged (15 minutes, 16°C, 11,500 g) and 280 µl of each 
supernatant was pipetted into a 96-well plate. The absorbance was read at 600 nm using a plate 
reader (SLT, Spectra). 
Because the full experiment samples harvested after two weeks (week 2) samples had 
higher GAG levels, a less sensitive assay was used. A 48 µl aliquot of each sample or standard 
was mixed with 300 µl of undiluted DMMB dye and incubated at room temperature for one 
hour. Samples and standards were centrifuged and 200 µl of the supernatant was pipetted into a 
96-well plate so the absorbance could be measured. 
The DMMB assay for the pilot preliminary experiment followed the same protocol as the 
week one samples, except that 40 µl of sample or standard were mixed with 250 µl of diluted 
DMMB dye. After centrifugation 200 µl of the supernatant were pipetted into the 96-well plates. 
3.3.3 Hoechst DNA Assay 
The Hoechst assay protocol for these experiments was the same as the one described in 
section 3.2.4. 
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3.3.4 RNA analysis 
While doing the DMMB assay and immunostaining are excellent ways of determining 
accumulation of ECM molecules within the hydrogels, mRNA analysis provides a “snapshot” of 
which genes are actively being transcribed into mRNA (and ostensibly being translated into their 
corresponding proteins). In addition, the immunostaining for collagen types I and II is 
qualitative, while the mRNA analysis allows for the quantification of the mRNA coding for these 
proteins. 
Samples for RNA analysis were thawed, then centrifuged (10 minutes, 12,000g, 4°C) to 
pellet any insoluble debris. The supernatant (approx. 390 µl) was moved to a fresh microtube, 
then 80 µl of chloroform was added and the mixture was incubated at room temperature for 5 
minutes. Samples were then centrifuged (15 minutes, 12,000g, 4°C) to separate the aqueous and 
organic phases. 150 µl of the upper aqueous (RNA-containing) phase was drawn off and mixed 
with an equal volume of 70% ethanol. This solution was then added to a HiBind RNA column 
from an E.Z.N.A™ Total RNA Kit (Omega, BioTek) and the manufacturer’s protocol for RNA 
isolation was followed. 
After RNA isolation, the A260/A280 ratio was measured to check for phenol or protein 
contamination. An A260/A280 ratio of 1.8 to 2.2 is characteristic of high quality RNA and the A260 
reading was used to determine RNA concentration. Then, cDNA was synthesised from this RNA 
using the QuantiTect® Reverse Transcription Kit (Qiagen) following the manufacturer’s 
protocol. Once synthesised, the cDNA was used as template for Real-Time Quantitative 
Polymerase Chain Reaction (qPCR) using Maxima® SYBR Green (Fermentas) reagents system 
in accordance with the manufacturer’s protocol. The amplification then took place in a thermal 
cycler (MJ Mini, BioRad) equipped with a mini-opticon fluorescence detection module. 
Expression levels of four types of gene transcripts were analyzed; the mRNAs which coded for 
collagen type I (col1α1), collagen type II (col2α1), aggrecan, and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) as a reference gene. The sequences of all qPCR primers used are 
described in Table 4. We designed each primer pair using the National Center for Biotechnology 
Information’s “Primer Blast” software, and following the qPCR primer design guidelines given 
by BioRad[151]. 
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Table 4. List of qPCR primers used in the present study. The optimal annealing temperature range was 
determined by an annealing temperature gradient. All primers were designed using the NCIB primer BLAST 
software, and validated using melt curves and electrophoresis. 
Gene 
GenBank 
Accession 
Number 
Forward Sequence 
(5’-3’) 
Reverse Sequence 
(5’-3’) 
Amplicon 
Size 
Optimal 
Annealing 
Temperature 
Range (°C) 
GAPDH DQ403065 
5’-
ACGGCAAGTTCCA
CGGCACAGT-3’ 
5’-
GTTGGCGGGATC
TCGCTCCTGG-3’ 
95 53.0 – 69.0 
Collagen 
Type II AF201724 
5’-
CAAAGATGGCGAG
ACAGGTGCT-3’ 
5’-
GAAGTCCCTGGA
AGCCAGATGGC-
3’ 
104 53.0 – 65.8 
Collagen 
Type I AF201723 
5’-
GACGCACGGCCAA
GAGGAGG-3’ 
5’-
CTGGCAGGGCAC
GGGTTTCC-3’ 
130 59.5 – 65.8 
Aggrecan NM_001164652 
5’-
GCTTCCGAGGTGT
CTCGGCG-3’ 
5’-
TCGTCTCCTCGCC
CACAGGG-3’ 
141 56.4 – 69.0 
To determine the optimum Polymerase Chain Reaction (PCR) annealing temperature for 
each gene-specific primer pair, a temperature gradient was run using cDNA from an untreated 
hydrogel which was fabricated in the manner described in Section 3.3.1 and cultured for 2 
weeks. Then, a standard curve prepared by a 5-fold serial dilution of the cDNA (5x, 1x, 1/5x, 
1/25x, 1/125x) was amplified at the optimum temperature to determine the efficiency of the PCR 
for each target gene. To ensure that each primer pair only amplified its specific target gene 
sequence, the PCR reaction products were separated by electrophoresis on a 15% polyacrylamide 
gel. In addition, a melt-curve analysis was carried out on all PCR products immediately 
following the amplification reaction to make sure that all products amplified were of the same 
size. No template controls (NTCs; i.e. PCR reaction mixtures lacking cDNA template) were run 
alongside the samples to check for amplification of primer-dimers or contamination of the 
reagents. In addition, 6 samples were randomly chosen for a “no reverse transcriptase controls” 
(NRTs) to check for genomic DNA contamination in the isolated RNA. For both the NTCs and 
NRTs if amplification took place more than 5 cycles after the lowest expressed transcript in the 
experimental samples it was considered negligible, as proposed by Bustin et al[152]. Finally, 6 
randomly chosen samples were analyzed on an automated electrophoresis machine (BioRad 
Experion System) to check for integrity of the input RNA that was used for the cDNA synthesis 
step that preceded qPCR amplifications. The Experion System measures an “RNA quality 
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indicator” which is a scale from 1-10, with 7-10 representing high quality RNA with negligible 
levels of degradation. 
Relative expression of each gene of interest normalised to GAPDH expression was 
calculated using the Pfaffl method[153]: 
Ratio = (Etarget)ΔCPtarget(control-sample)/(Ereference)ΔCPreference(control-sample)  (3.1) 
where Ratio is the relative expression ratio, Etarget and Ereference are the measured PCR  
amplification efficiencies of the target and reference genes, respectively, and ΔCPtarget(control-
sample) and ΔCPreference(control-sample) are the differences in crossing points between a control 
versus a sample for the target and reference genes, respectively. 
For the purposes of determining whether the CS, HA, and HACS hydrogel supplements 
had an effect on the levels of  mRNAs for the aggrecan, collagen type I, and collagen type II 
genes, the untreated hydrogel samples served as the “control,” whereas the CS, HA, and HACS 
supplemented hydrogels were each individually treated as “samples.” In addition, untreated 
hydrogel cultures were compared to RNA from freshly isolated chondrocytes and chondrocytes 
that had been cultured in conventional two-dimensional monolayer to assess how well the 
hydrogels helped the chondrocytes retain their differentiated phenotype. Chondrocytes that retain 
their phenotype would be expected to synthesize significantly more collagen type II than 
collagen type I[154], so difference in expression of the mRNA transcripts in these two genes was 
determined. 
3.3.5 Cryogenic Sectioning 
One sample from each treatment group at each time point was used for histological 
sectioning and staining. Hydrogels were rinsed in Hank’s saline solution for 2 minutes. The 
saline was then removed and the hydrogel was immersed in formaldehyde solution (3.7% 
formaldehyde in Lonza’s phosphate buffered saline (PBS) supplemented with Mg++ and Ca++) 
for 30 minutes to fix the cells. The fixed hydrogel samples were then soaked overnight in a 
sucrose cryopreservation solution (30% sucrose in PBS supplemented with Mg++ and Ca++). 
Then samples were embedded in Optimal Cutting Temperature Compound (Tissue-Tek) and 
frozen at -20°C initially, then transferred to -80°C for long-term storage. The samples were later 
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cryogenically sectioned using a cryostat (HM 550, Thermo Scientific) at a thickness of 30 µm. 
The sections were placed on glass microscope slides (Superfrost Plus, Fisher Scientific) and 
stored at -20°C. 
The sections were subjected to immunostaining to detect the presence of collagen types I 
and II. First the sections were washed 2x with PBS containing 0.01% Tween 20 (PBST), for 5 
minutes per wash. The sections were then incubated in a blocking solution of PBST containing 
5% sheep serum (Sigma) for one hour. The blocking solution was replaced with the diluted 
primary antibody and allowed to incubate at room temperature for 1 hour. The primary antibody 
solution for collagen type II (hybridoma supernatant, monoclonal, anti-chicken collagen II;  II-
II6B3, DSHB) was diluted 1:25 with PBST containing 5% sheep serum, while the collagen type 
I antibody solution (monoclonal, cat# 2456, Sigma) was diluted 1:200. Following the primary 
antibody treatment, the sections were washed 4x with PBST (10 minutes per wash). Then the 
sections were incubated for 1 hour at room temperature in a 1:200 dilution of alkaline 
phosphatase-conjugated goat anti-mouse secondary antibody (400 µg/ml stock; Santa Cruz 
Biotechnology) in PBST containing 5% sheep serum. Then, the sections were washed 3x with 
PBST containing 0.5 mg/ml levamisole (10 minutes per wash), followed by two washes in 
NTMT (100 mM Tris HCl, pH 9.5, 50 mM MgCl2, 100 mM NaCl, 1 mg/ml Triton X-100, 0.5 
mg/ml levamisole) (for 15 minutes per wash). Finally, the sections were incubated overnight at 
room temperature in colour development solution (NTMT supplemented with 0.34 mg/ml 
nitroblue tetrazolium chloride and 0.175 mg/ml 5-bromo-4-chloro-3-indolylphosphate). The 
colour development reaction was stopped by three, 5 minute washes in PBST. As a negative 
control, a parallel section was treated as above, except that the primary antibody incubation step 
was omitted. 
3.3.6 Statistics 
For both the DMMB and the Hoechst assays a minimally-adequate mixed-effects linear 
model, with the untreated group as the intercept, was used to identify significant interactions 
using the model simplification techniques presented in [155]. The reason for using a mixed-
effects model was that during the initial mixing of the hydrogels, the fibrinogen and alginate for 
each treatment group were pre-mixed in a large batch. As the individual gels were fabricated, 
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this batch separated out and the later gels received slightly more fibrinogen than the earlier ones. 
Fortunately, the order that the gels were fabricated was recorded, thus allowing for gels that were 
fabricated at the same time to be blocked together. By listing these blocks (each containing one 
sample of each treatment) as a random effect in the model it effectively “filtered out” the effects 
of the differing hydrogel compositions and allowed the treatments of interest (in this case the 
HA/CS treatments) to be fairly compared to one another. The results of this minimally-adequate 
model were used solely to determine if there was a significant interaction between HA and CS. 
To examine if the hydrogel samples supplemented with HA, CS, or HACS were 
significantly different from the untreated group, a separate mixed-effects linear model was fit to 
the data that treated the HACS group as a separate treatment, rather than as an interaction of the 
HA and CS treatments. The results from this model were used to determine which, if any, of the 
three groups of hydrogels treated with macromolecules were significantly different from the 
untreated control. In addition, to test for cell proliferation, only the untreated groups from weeks 
0, 1, and 2 were compared to one another. In this case, it was not possible to use a mixed-effects 
model as we were not comparing the effects of treatments within the same block. Therefore, a 
simple analysis of variance (ANOVA) was used to see if total cell numbers were significantly 
different between the time points, and a Tukey’s Honest Significant Differences post-hoc test 
was used to determine which time points were significantly different from one another. A box 
and whisker plot of the data was used to visually confirm that it was normally distributed. 
 The data from the preliminary pilot experiment did not require a mixed-effects linear 
model either as each gel was pre-mixed separately before seeding, eliminating the problem of the 
gel separating out. Therefore, a traditional general linear model was used for this data. Finally, 
the DMMB readings were normalised to the amount of DNA in each sample, to account for any 
differences in total cell numbers. 
For qPCR data, conventional parametric statistical tests may not be used because the 
mRNA expression ratio data derived from equation 3.1 do not follow a normal distribution. In 
response to this, the Relative Expression Software Tool (REST)[156] was developed with the 
intention of enabling qPCR users to apply robust non-parametric statistical tests to their data. 
REST uses a randomized resampling algorithm to determine if a specific gene transcript is 
significantly up regulated or down regulated, and bootstrapping methods to derive a 95% 
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confidence interval for the calculated mRNA expression ratio. Both of these statistical tests have 
the advantage of not needing to assume any type of distribution, making them appropriate for the 
analysis of qPCR data. 
Another qPCR analysis compared the expression levels of aggrecan, type I and type II 
collagens in hydrogel cultures to the corresponding levels of chondrocytes in traditional two-
dimensional monolayer cultures. In this case, the “samples” in equation 3.1 were the week 1 
untreated hydrogels (n=7), chondrocytes cultured in monolayer for 6 days (n=3), and 12 days 
(n=3), whereas freshly isolated chondrocytes (n=3) were used as the “control.” 
In addition to determining if collagen types I and II and aggrecan were significantly up or 
down regulated, the REST program was used to determine if more collagen type II was present 
than collagen type I. To do this, it was assumed that the genes had a common amplification 
efficiency of 102% (amplification efficiencies were empirically measured as 101.9 for collagen 
type II and 102.2 for collagen type I). With this assumption equation 3.1 becomes: 
Ratio = (Ecollagen)ΔCPtarget(collagen type I-collagen type II)   (3.2) 
where collagen type I and collagen type II represent the amplification cycle at which the 
respective collagens cross the qPCR detection threshold. If the expression ratio is significantly 
different from one (Ratio=1 if the mRNAs for these collagens are present in equal quantities), 
then collagen type I and collagen type II mRNA concentrations are significantly different from 
one another. This analysis was done for chondrocytes that were freshly isolated (n=3), cultured 
for 6 days in monolayer (n=3), 12 days in monolayer (n=3), and the week 1 untreated hydrogels 
(n=7). 
3.4 Composite Solid/Hydrogel Scaffolds Fabrication and Characterization 
3.4.1 Composite Scaffold Fabrication 
The solid portion of the composite scaffolds was fabricated in a manner similar to the 
scaffolds made in Section 3.2.1. In brief, the PLGA/IO material slurry was mixed identically to 
the slurry for the earlier scaffolds. These scaffolds were fabricated using a different RP machine 
(3D-Bioplotter, Envisiontec) than the previous dispensing system. The 3D-Bioplotter, shown in 
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Figure 16, is specifically designed for scaffold fabrication and makes the adjustment of pore size, 
bulk dimensions, and dispensing pressure much simpler. It was acquired after the scaffolds 
described in Section 3.2.1 were fabricated. The programmed (before shrinking) bulk dimensions 
of the scaffolds were 7.0 mm x 7.0 mm x 3.0 mm with a horizontal pore size of 450 µm and a 
strand diameter of 250 µm. The slightly larger pore size (compared to the scaffolds described in 
Section 3.2.1) was to ensure that a hydrogel mixture would be able to freely flow into the 
fabricated solid scaffold. After deposition, scaffolds were placed in a fume hood overnight to 
allow the chloroform to evaporate and the scaffolds to harden. Once hard, the scaffolds were cut 
into cylinders using a dermal biopsy punch with a 5 mm diameter. Before any cell culture work, 
scaffolds were sterilized in 70% ethanol for 30 minutes and rinsed with Hank’s saline. 
Figure 16. The 3D-Bioplotter was used to fabricate the solid scaffold portion of the composite scaffolds. It 
worked in a similar manner to the RP machined presented in Figure 14 except that it had software more 
appropriate for scaffold fabrication. That is, it moved along a pre-programmed path and sequentially 
deposited layers one on top of another. 
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Cells were isolated following the protocol outlined in Section 3.2.3 and the cell 
suspension was mixed with the fibrinogen and alginate hydrogel components as described in 
Section 3.3.1. The final cell density of the hydrogels was 2x107 cells/ml. This cell concentration 
was chosen as it was the most concentrated cell concentration that could be accurately pipetted. 
Then, the cylindrical solid scaffolds were press-fit into 5 mm diameter plastic moulds (Figure 
17). With the solid scaffolds ready, the thrombin was added to the fibrinogen/alginate/cell 
suspension mixture such that the final concentration was 2.5 U/ml in the hydrogel. The reason 
that the thrombin concentration employed was only ¼ the concentration of our previous 
hydrogels was to decrease the rate of fibrinogen polymerization, thereby allowing the gel to flow 
through the solid scaffold more easily without affecting the final consistency of the 
hydrogel[149]. For each of the four composite (n=4) scaffolds, 120 µl of hydrogel was pipetted 
into each well of a 4-well tissue culture plate and negative pressure was applied to immediately 
suck the hydrogel into the solid scaffold. The composite scaffolds were allowed to sit for 30 
minutes to allow the fibrinogen to gel. Then the moulds containing scaffolds were submerged in 
102 mM CaCl2 for 30 minutes to crosslink the alginate. The composite scaffolds were then 
ejected from the moulds and rinsed with Hanks’s saline, after which any excess hydrogel not 
encapsulated within the scaffold was trimmed off. Scaffolds were then placed in individual wells 
of a 96-well plate and bathed in DMEM/10%FBS/GAK medium supplemented with 0.1 mg/ml 
CS. 
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Figure 17. A (a) schematic and, (b) photographs of one of four identical moulds used in the composite scaffold 
fabrication process. Solid scaffold were pressed into the threaded end of the bolt and negative pressure was 
applied to the head end to suck the hydrogel into the solid scaffold. The cap nut was secured immediately 
afterwards to keep the hydrogel in place while gelation took place. 
To determine the efficacy of these composite scaffolds, a set of four (n=4) solid scaffolds 
(without hydrogels) were also seeded with chondrocytes. The scaffolds, which were identical to 
those used for the composite scaffolds, were placed in a 96-well plate and a cell suspension of 
2x107 cells/ml was pipetted on top of them. Each well had 70 µl of cell suspension added to it, 
which represented just enough volume to completely cover the scaffold.  
The cells were allowed 1 hour to settle to the bottom of the dish and start adhering to the 
solid scaffolds. After 1 hour, 250 µl of DMEM/10%FBS/GAK supplemented with 0.1 mg/ml CS 
was gently added to each well and the plates were incubated overnight (37ºC, 100% RH, 5% 
CO2). The scaffolds were then transferred to individual wells of 4-well tissue culture plates and 
maintained in DMEM/10%FBS/GAK supplemented with 0.1 mg/ml CS for one week, with a 
single medium change on day 4. 
3.4.2 Hoechst and DMMB Assays 
After one week, the scaffolds were removed from the 4-well plates and placed in a 96-
well plate. A 100 µl aliquot of hydrogel dissolution solution (described in Section 3.3.1) was 
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added to each well, and samples were digested for 4 hours. Then a 30 µl aliquot of the digest was 
diluted with 30 µl triple-distilled water to bring the concentration of alginate to 1 mg/ml, and this 
mixture was stored at 4ºC. The remaining digest was centrifuged (5 minutes, 4°C, 300 g), 
resuspended in 100 µl of Hank’s saline, and frozen at -20ºC. 
The DMMB assay was performed in a manner similar to the week 1 samples from 
Section 3.3.2 except that 40 µl of the diluted sample was mixed with 250 µl of diluted DMMB 
dye. 
The Hoechst assay was performed using the same protocol outlined in Section 3.2.4. 
3.4.3 Statistics 
As this experimental design had only one treatment group and one control group a 
student’s-t test was used to test for significance. 
3.5 Preliminary Results 
During the initial phases of this project, some preliminary work done to verify that viable 
chondrocytes could indeed be cultured in the hydrogels, and that the cells were producing 
proteoglycan-rich ECM. This work provided some excellent visual evidence of the cells’ 
behaviour, but was not repeated in later experiments due to time constraints. 
3.5.1 Hoechst Staining of Hydrogels 
As an early test of cell viability, Hoechst 33342 dye was used to stain the nuclei of cells 
while in hydrogel culture. A 4 µg/ml solution of Hoechst 33342 was placed on top of the culture 
and incubated for 30 minutes at 37°C. Cultures were then rinsed twice with Hanks’ saline, and 
allowed to sit in fresh Hanks’ while being photographed under a fluorescence microscope 
(Olympus). 
To determine if cells were surviving throughout the hydrogels, one sample was 
cryogenically sectioned as described in Section 3.3.5 and stained with Hoechst dye. The sections 
were rehydrated with PBS for five minutes, incubated in a 4 µg/ml Hoechst 33342 solution for 
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15 minutes, and rinsed 3x with PBS. The sections were then place in mounting solution 
(LabVision) and photographed using a fluorescence microscope. 
3.5.2 Alcian Blue Staining of Hydrogels 
Representative cultures of chondrocytes in hydrogels were stained overnight with Alcian 
blue dye (0.2% Alcian blue in 0.1 M HCl, pH=1) which binds to the GAG present in cartilage 
proteoglycans. The Alcian blue dye solution was removed and the cultures were briefly 
incubated with 0.1 M HCl to release any stain that was not bound to matrix GAGs. The cultures 
were then photographed using a dissection microscope (Wild, Heerbrugg). 
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Chapter 4: Results 
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4.1 Solid Scaffold Experiment 
We employed microtomography to ensure that there were overhanging structures (i.e. 
interconnected pores) throughout the scaffold. These interconnected pores are crucial as they are 
the volume in which the chondrocytes proliferate, as well as allowing for medium exchange. 
Scaffolds were successfully fabricated by the rapid-prototyping method using the PLGA-
IO material slurry. As shown in Figure 18, the scaffolds had highly controlled and reproducible 
geometries. The micro-CT image analysis revealed that there were indeed overhanging structures 
throughout the scaffold (Figure 19). The mean pore size, strand diameter, and porosity for each 
of four replicate scaffolds produced are presented in Table 5. 
Figure 18. Photograph of solid scaffold taken with a dissecting microscope. The marks on the ruler at the top 
of the figure delineate 1mm increments. 
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Figure 19. Three-dimensional model built from the microtomography data showing the (a) exterior and a (b) 
tomographic cross section. The cross section shows that there are overhanging structures (i.e. interconnected 
pores) throughout the scaffold as pointed out in the (c) magnified portion of this cross section. 
Table 5. Summary of the scaffold parameters as measured by micro-CT image analysis. The 4 scaffolds 
measured were fabricated using the same RP program parameters. The pore size and strand diameters are 
presented as mean ± standard deviation. The cumulative average for each parameter is also presented. 
Scaffold # Pore Size (mm) Strand Diameter 
(mm) 
Porosity (%) 
1 0.169±0.055 0.259±0.066 33.99 
2 0.125±0.038 0.306±0.085 19.72 
3 0.187±0.058 0.230±0.056 41.39 
4 0.168±0.048 0.250±0.066 35.01 
Cumulative 
Average 0.162 0.261 32.53 
Once it was determined that a scaffold with interconnected pores could be fabricated 
using a PLGA-IO material slurry it was necessary to show that cells could be cultured on this 
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material. For this purpose, cells were cultured on disks of the PLGA-IO material slurry and on 
disks of PLGA-HAP and a tissue culture plate for comparison. A Hoechst DNA assay was used 
to determine cell number (as indicated by total DNA content) after one week of culture. This 
assay measured the amount of fluorometric dye bound to DNA within a homogenized sample. 
Therefore, the fluorometric intensity was assumed to be indicative of the amount of DNA in the 
sample. Moreover, the DNA content was assumed to reflect the total cell number because each 
chondrocyte contains an equivalent amount of nuclear DNA during most of the cell cycle. 
Results of the Hoechst DNA assay (Figure 20) revealed that significant numbers of cells 
survived on both the PLGA-IO and PLGA-HAP scaffold materials. Unseeded scaffold materials 
had no detectable DNA. Seeded PLGA-IO had significantly more associated cellular DNA than 
either seeded PLGA-HAP substrates or the seeded wells of tissue culture dishes lacking these 
substrates. Hoechst staining provided visual evidence that the cells could attach to and survive on 
the PLGA-HAP and PLGA-IO scaffold materials (Figure 21). However, the cells on these 
substrates were not homogeneously distributed, making it impossible to count cells and thereby 
confirm the results of the Hoechst DNA assay (i.e. that the PLGA-IO substrate had significantly 
more cells than the PLGA-HAP substrate). 
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Figure 20. Hoechst DNA assay results from the scaffold substrate experiment (n=8 for each group). A *** 
represents p<0.001, ** p<0.01, and * p<0.05, and the error bars represent one standard deviation for this and 
all following figures unless otherwise noted. 
66 
 
Figure 21. Hoechst DNA staining of porcine chondrocyte nuclei on the (a) PLGA-HAP and (b) PLGA-IO 
scaffold materials after two days of culture. Photographed using a 10x objective on a Olympus fluorescence 
microscope. 
4.2 Hydrogel Preparation and Characterization 
4.2.1 Results from Preliminary Pilot Experiment 
The DMMB GAG quantification assay was used to quantify matrix production (indicated 
by sulphated GAG levels) in supplemented samples and non-supplemented hydrogels. Results 
from the DMMB GAG quantification assay showed that after ten days in culture there were 
significantly more total GAGs in the CS, HA, and HACS supplemented hydrogels compared to 
the untreated (without supplementation) hydrogel control. These treatments all had 
approximately twice as much total GAGs as the untreated group. In addition, the general linear 
model revealed that there was a significantly negative interaction between HA and CS (p=0.027). 
An inspection of Figure 22 shows that the effects of the CS and HA were not additive in the 
HACS group, supporting the results of the aforementioned general linear model. 
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It should be noted that the 10 minute rinse with Hanks’s saline before digestion of the 
hydrogel (Section 3.3.1) sufficiently rinsed the solubilised CS and HA from the supplemented 
hydrogels so that they did not interfere with the DMMB GAG quantification assay (data not 
shown). In addition, the purpose of the lower pH in this assay is to reduce the binding of the 
DMMB dye to carboxyl group, thereby increasing the specificity of the assay for the sulphate 
groups present in suphated GAGs and reducing the effects of other carboxylated molecules like 
HA and alginate[150]. 
Figure 22. Amount of total GAG produced per each µg of DNA for each of the four treatments (n=3 for each 
group). The untreated controls were not supplemented with either HA or CS. A *** represents p<0.001, ** 
p<0.01, and * p<0.05, and the error bars represent one standard deviation. 
The Hoechst DNA assay was used to quantify cell population within the hydrogels. The 
assay revealed that there was significantly less DNA (i.e. fewer cells) in the HA supplemented 
cultures compared to the untreated cultures after ten days of incubation, as shown in Figure 23. 
The DNA content of the CS and HACS supplemented hydrogels was not significantly different 
than the untreated control group. 
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Figure 23. Amount of DNA for each of the four (n=3 for each) macromolecule treatments after ten days of 
culture. The untreated controls represent hydrogels that were not supplemented with HA or CS. A *** 
represents p<0.001, ** p<0.01, and * p<0.05, and the error bars represent one standard deviation. 
4.2.2 Results from Full Hydrogel Supplementation Experiment 
Again, this full hydrogel experiment was similar to the preliminary pilot study completed 
earlier. The main differences between these two studies were the increased number of replicates, 
performing two time points for the DMMB and Hoechst assays, and an initial time point for the 
Hoechst assay to measure cell proliferation, immunostaining of the week 1 and 2 samples, and 
RNA analysis of the week 1 samples. 
The results of the DMMB GAG quantification assay indicate that after one week of 
culture, there was approximately twice as many GAG in the hydrogels supplemented with CS, 
HA, and HACS compared to untreated wells. This paralleled the results obtained in the 
preliminary pilot experiment. The mixed-effects linear model fit to the week 1 data suggests that 
there was a significant negative interaction between the HA and CS (p=0.0049). A negative 
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interaction in the context of this experiment suggests that the effects the HA and CS have 
individually on chondrocytes in hydrogel culture do not sum with one another when hydrogel 
cultures are supplemented with both macromolecules. Figure 24 shows that the effects of the CS 
and HA were indeed not additive, supporting the findings of the mixed-effects linear model. 
Figure 24. The effects of macromolecule stimulation on total GAG per µg DNA production at week 1 (n=7 for 
each treatment), and week 2 (n=5 for each treatment). A *** represents p<0.001, ** p<0.01, and * p<0.05, and 
the error bars represent one standard deviation. 
The week 2 data showed a reversal of the trend found in week 1, with the untreated 
control hydrogels containing significantly more µg GAGs/µg DNA than either the HA or HACS 
treated groups. The CS supplemented hydrogels did not have significantly different levels of µg 
GAG/µg DNA than the non-supplemented hydrogels. In this case, there was not a significant 
statistical interaction (mixed-effects linear model) between the HA and the CS treatment effects 
(p=0.687), suggesting that their effects on GAG production per cell were neither antagonistic nor 
synergistic. 
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The Hoechst DNA assay showed that there was roughly a two-fold increase in cellular 
DNA (i.e. cell numbers) in the untreated hydrogel controls during the first week, but that the cell 
population did not significantly increase during the second week, as shown in Figure 25. As with 
the DMMB assay, the results for week 1 were similar to those observed in my earlier preliminary 
experiment. That is, that the HA, CS, and HACS treated hydrogels had slightly lower mean 
cellular DNA than the untreated hydrogel control, although the decrease was not significant at 
this time point. In addition, there was no significant interaction between the HA and CS 
treatment effects (p=0.112). 
Figure 25. The effects of macromolecule stimulation on cell population at week 0 (n=5), week 1 (n=7 for each 
treatment), and week 2 (n=5 for each treatment). Untreated hydrogels were not supplemented with either HA 
or CS. A *** represents p<0.001, ** p<0.01, and * p<0.05, and the error bars represent one standard 
deviation. 
In contrast, by week 2 of culture the CS and HACS treated hydrogels had accumulated 
significantly more cells than the untreated hydrogel control. There was no significant interaction 
between the HA and the CS treated hydrogels (p=0.394). Since the higher cell populations in the 
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week 2 CS and HACS treated hydrogels might account for the lower µg GAG/µg DNA in the 
week 2 samples (Figure 24). It was important to see what effects the macromolecule treatments 
had on the non-normalised GAG accumulation. As shown in Figure 26, there was still a roughly 
two-fold increase in GAG production in HA, CS, and HACS supplemented hydrogels after one 
week in culture, but that for the week 2 samples there was no significant difference in the total 
amount of GAG produced. Note that the mixed-effects linear model shows that there was a 
negative interaction between the HA and CS treatment effects for both week 1 (p=0.0115) and 
week 2 (p=0.0378).  
Figure 26. Amount of total GAG present in hydrogel cultures over a two week period when not normalised to 
DNA amount (n=7 for each treatment group in week 1; n=5 for each treatment group in week 2). Untreated 
hydrogels were supplemented with neither HA or CS. A *** represents p<0.001, ** p<0.01, and * p<0.05, and 
the error bars represent one standard deviation. 
To determine the levels of mRNAs which coded for collagen type I (col1α1), collagen 
type II (col2α1), aggrecan, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), qPCR 
was used. To show matrix accumulation in the hydrogels during culture the DMMB GAG 
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quantification assay determined the amount of total sulphated GAG (present in proteoglycans), 
while the immunostaining provided qualitative information about the collagen types I and II 
levels. Determining mRNA levels for aggrecan (present in aggregating proteoglycans) and 
collagen types I and II ostensibly allowed for quantification of the production of these proteins at 
the time of RNA collection. As mentioned in Section 1.1, high levels of proteoglycans and 
collagen type II and low levels of collagen type I suggest that chondrocytes are retaining their 
phenotype. The GAPDH levels were used to normalise the expression levels of aggrecan and the 
collagen types I and II. 
The temperature gradient optimization revealed that an annealing a PCR temperature of 
65.8ºC gave a high efficiency value for all 4 genes of interest. In addition, the melt curve 
analysis and polyacrylamide gels showed that there was only a single amplification product for 
each of the genes at this temperature (Figure 27). Standard curves were run for each of the genes, 
as shown in Figure 28, with the 65.8ºC annealing temperature and these gave PCR amplification 
efficiencies of between 103.6 and 92.8%, which is within the acceptable range given by the 
thermal cycler’s manufacturer[151] and MIQE guidelines[152]. 
Figure 27. The PCR products, amplified at the optimized annealing temperature of 65.8°C, for the four genes 
of interest were run on a polyacrylamide gel and all showed only a single band at the designed amplicon 
length shown in Table 4. The bottom ladder band is 50 base pairs and the second from the bottom is 100 base 
pairs.  
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(a) Collagen type II 
(b) Collagen type I 
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(c) Aggrecan 
(d) GAPDH 
Figure 28. Standard curves for the (a) collagen type II, (b) collagen type I, (c) aggrecan and, (d) GAPDH  
primers showing that all PCR efficiencies were close to 100%. Each standard curve is based on a 5-fold serial 
dilution of the cDNA (5x, 1x, 1/5x, 1/25x, 1/125x) with each concentration done in triplicate. All efficiencies 
and correlation coefficients were within the acceptable range given by the manufacturer of the thermal 
cycler[151] and MIQE guidelines[152].  
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With the PCR reactions optimized and the amplification efficiencies determined it was 
now possible to run the experimental samples and calculate their relative expression ratios using 
equation 3.1. Normalised gene expression is the amount of target gene (col1α1, col2α1, 
aggrecan) mRNA normalised to the amount of GAPDH mRNA. The relative expression ratio is 
the ratio of normalised gene expression in the HA, CS, and HACS supplemented hydrogels 
(samples), and the normalised gene expression in the non-supplemented hydrogels (controls). 
The REST software showed that there was no significant up or down regulation of any of the 
target genes when comparing the three different treatments to the untreated control group. In 
other words the relative expression ratios, R, for the CS, HA, and HACS treatments were not 
significantly different from 1 (R for the untreated control group), as shown in Figure 29. 
It should be noted that for the HA treated group, one of the samples failed to amplify a 
PCR product. This could be due to some contaminant in the sample which inhibited either the 
reverse transcriptase step of the cDNA synthesis or the PCR reaction itself. Therefore, for the 
HA group there are only 6 samples as opposed to the 7 for all the other conditions. However, this 
would not compromise the statistical analysis as the randomization test used in REST can be 
used with groups of unequal size. 
The comparisons of gene expression levels in chondrocytes cultured in the untreated 
hydrogel versus chondrocytes cultured on conventional tissue culture plates for 6 or 12 days 
versus freshly isolated (uncultured) chondrocytes shown in Figure 30. In this case, the relative 
expression ratio (equation 3.1) used the untreated hydrogels and conventional cultures as the 
samples, while the uncultured chondrocytes were used as the controls. The collagen type II 
mRNA levels were significantly higher in the non-supplemented hydrogel and the day 6 
monolayer cultures, but were significantly lower in day 12 culture relative to the freshly isolated 
chondrocytes. The results for aggrecan gene expression were similar to the collagen type II 
results except that the aggrecan mRNA level in the day 12 sample was not significantly lower 
than the freshly isolated chondrocytes. The collagen type I gene expression was much higher in 
chondrocytes cultured for 6-12 days on standard tissue culture plastic than in chondrocytes 
within untreated hydrogels, again with all three measured relative to normalised mRNA 
expression levels in freshly isolated chondrocytes. 
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The collagen type II to collagen type I ratios presented in Figure 31, show that the 248x 
collagen type II is much higher than the 12x ratio for the untreated hydrogel, the 1.7x ratio for 
the day 6 chondrocytes, and the 0.1x ratio for the day 12 chondrocytes. In this case the collagen 
type II gene expression level was treated as the sample and the collagen type I level treated as the 
control as reflected in equation 3.2. These relative expression ratios were calculated using REST 
software, which used bootstrapping to determine the spread of data.  
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(a) 
(b) 
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(c) 
Figure 29. Plot of the relative expression of the mRNA that encodes for (a) collagen type II, (b) collagen type I 
and, (c) aggrecan in the CS (n=7), HA (n=6), and HACS (n=7) groups relative to the non-supplemented 
hydrogel control group. The bar height represents the median and the error bars represent standard error as 
calculated by REST. The relative expression ration (R) is 1 for the untreated hydrogel. 
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(a) 
(b) 
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(c) 
Figure 30. Results of the qPCR reaction showing how the mRNA expression of the target genes in the 
untreated hydrogel samples (n=7), and chondrocytes cultured on a conventional tissue culture plate for 6 
(n=3) or 12 (n=3) relative to freshly isolated chondrocytes (n=3). The mRNA that encodes for (a) collagen type 
II, (b) collagen type I and, (c) aggrecan were investigated. Bar height represents the median value and error 
bars represent the standard error as calculated by REST. R=1 for the freshly isolated chondrocytes. 
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Figure 31. Relative amounts of collagen type II mRNA to collagen type I mRNA for chondrocytes that were 
freshly isolated (n=3), cultured in an untreated hydrogel for one week (n=7), or cultured in monolayer on a 
tissue culture plate for 6 (n=3) or 12(n=3) days. The relative expression ratio used the collagen type II mRNA 
expression level as the sample and the collagen type I level as the control, as indicated in equation 3.2. Bar 
height represents the median value and error bars represent the standard error as calculated by REST. R=1 
when col2α1 and col1α1 have the same level of gene expression. 
Immunostaining with antibodies specific for collagen type I and collagen type II proteins 
demonstrated the accumulation of both types of collagen in hydrogels at week 1 and 2 of culture 
(Figure 32). This staining suggests that the collagen type II and type I mRNAs detected by qPCR 
were indeed being translated into proteins. 
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Figure 32. Immunostaining of cryogenic sections of the full hydrogel supplementation experiment. Staining 
revealed that there was an accumulation of collagen types I and II proteins over time. The negative controls 
were incubated with 5% Sheep Serum in PBST instead of the 1° antibodies. We used a Leica microscope 
using the 10x objective. 
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4.3 Composite Scaffold Fabrication and Characterization 
The PLGA-IO scaffold proved suitable for both scaffold fabrication and chondrocyte 
culture. In addition, cells were successfully cultured within the fibrin-alginate hydrogel and it 
was demonstrated that supplementation had a positive short-term effect on sulfated GAG 
accumulation. This experiment infused a hydrogel supplemented with CS into a mechanically 
stable PLGA-IO solid scaffold in an attempt to demonstrate that cell proliferation and matrix 
accumulation was higher in a composite scaffold compared to a solid scaffold not impregnated 
with the hydrogel. 
The solid scaffolds were successfully impregnated with the seeded hydrogel, as shown in 
Figure 33, whereas the solid scaffold controls (without hydrogel) sat in a dense cell suspension 
for seeding. The DMMB assay showed that there was significantly less sulphated GAG 
accumulation in the solid scaffold controls than in the composite scaffolds. The amount of GAG 
detected for the composite scaffold was essentially 0 µg while the amount in the solid scaffold 
controls was -1.5 µg. It is noted that there is not actually a negative mass of sulphated GAG, but 
rather that less of the DMMB dye was bound in the solid scaffold control samples than in the 0 
µg/ml standard. This is likely due to some of the alginate present in the 0 µg/ml standard binding 
with the DMMB dye while the solid scaffolds without hydrogel lacked alginate. The Hoechst 
DNA assay showed that there were significantly more cells in the composite scaffolds than the 
controls, as shown in Figure 35. 
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Figure 33. Photograph of the composite scaffold showing that the fibrin-alginate hydrogel could indeed be 
infused within the solid scaffold framework. The diameter of the solid scaffold is 5 mm. 
Figure 34. Results of the DMMB assay showing that the composite scaffolds (n=4) was almost identical to the 
0 µg standard and the solid scaffold without hydrogel (n=4) had a DMMB reading significantly lower than 
the 0 µg standard. A *** represents p<0.001, ** p<0.01, and * p<0.05, and the error bars represent one 
standard deviation. 
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Figure 35. Results of the Hoechst DNA assay for the composite scaffold experiment showing that there were 
significantly more cells in the composite scaffolds (n=4) than in the solid scaffold controls (n=4). A *** 
represents p<0.001, ** p<0.01, and * p<0.05, and the error bars represent one standard deviation. 
4.4 Preliminary Results 
4.4.1 Hoechst Staining of Hydrogels 
The Hoechst staining of the hydrogels, shown in Figure 36, showed that the cells were 
indeed surviving throughout the hydrogel and were evenly distributed. 
Figure 36. Hoechst staining of (a) chicken sternal chondrocytes after 5 days of culture while still in the 
hydrogel, and (b) porcine chondrocytes in a cryogenically sectioned cross-section from the preliminary pilot 
hydrogel experiment (Olympus microscope; 10x objective). 
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4.4.2 Alcian Blue Staining of Hydrogels 
Alcian Blue histochemical staining, shown in Figure 37, of some of the early hydrogel 
cultures provided visual evidence that the embedded chondrocytes were indeed producing 
sulphated GAG. This indicates that the chondrocytes were retained their phenotype in the 
hydrogels. 
Figure 37. Alcian Blue staining of chicken sternal chondrocytes in the fibrin-alginate hydrogel after 8 days of 
culture showing a sphere of secreted proteoglycans around each of cluster of cells (dark spots in the centre of 
the blue spheres). Photograph taken using a dissecting microscope (Wild dissecting microscope, 40x 
objective). 
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Chapter 5: General Discussion 
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5.1 Solid Scaffold Fabrication and Experimentation 
The purpose of this portion of the project was to determine if solid scaffolds could be 
fabricated with a PLGA-IO material slurry, and if so, to find if this material could support 
chondrocyte culture. This study represents the first time that IO has been used as the nanoparticle 
in a material slurry used for scaffold fabrication. 
Both the photographic evidence and the microtomography showed that it is indeed 
feasible to fabricate scaffolds with overhanging structures (i.e. interconnected pores) with the 
PLGA-IO material slurry. The microtomography data allows the virtual sectioning of these 
scaffolds and confirms that the internal geometry contains repeating overhanging structures and 
that there is interconnectivity between the pores. This is important because interconnected pores 
are necessary for chondrocyte proliferation and medium exchange[47]. By examining the cross 
sections of scaffolds fabricated in the present study (Figure 19), obtained by microtomography, it 
is apparent that there is some fusion between the scaffold layers. This suggests that the IO 
concentration in the slurry was appropriate for solid scaffold fabrication. These overhanging 
structures would not be possible if the IO concentration was too low as the scaffold would fall in 
on itself, whereas an excessive IO content would prevent flow through the needle and 
sequentially fabricated layers from fusing with one another at their points of intersection, as 
demonstrated in an earlier study by Li et al[157]. 
By using the porosity equation[47] with the assumption that there is no fusion between 
the layers and no shrinking in the scaffolds as the chloroform evaporates, the porosity of these 
scaffolds was evaluated as 61% from the design parameters listed in Section 3.2.1. It is noted 
that the porosity measured using the microtomography data, shown in Table 5, was much smaller 
than the above evaluated value. This discrepancy is mainly caused by the partial fusion of the 
layers in the scaffold and the scaffolds undergoing some shrinking as they dried. It is important 
to take this shrinking into account when designing the initial dimensions of the scaffold as the 
final pore size will affect both chondrocyte proliferation and matrix production[50]. 
Culturing chondrocytes on this scaffold material as compared to a previously reported 
PLGA-hydroxyapatite (HAP) material slurry[48, 55] and a flat tissue culture surface showed that 
significantly more cells survived on the PLGA-IO material. Both the Hoechst DNA staining and 
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the Hoechst DNA assay showed that a significant number of cells survived on this material after 
one week of culture. This suggests not only that chondrocytes can be successfully cultured on a 
material comprised of both PLGA and IO, but that in terms of cell survivability this composite 
material is actually preferential to a PLGA-HAP scaffold material slurry. 
These findings compared favourably to previous reports describing scaffolds that were 
fabricated with a PLGA-based material slurry which successfully created interconnected pores 
with pore sizes similar to the ones used in the present study[48, 55]. In addition, previous studies 
have also successfully used PLGA-based material for chondrocyte culture[52, 55, 57-60], while 
others have shown that IO has no detrimental effects on both chondrocyte phenotype[66] and 
survivability[65]. 
One of the real strengths of this study is the direct comparison to the biodegradable 
polymer and HAP scaffold material slurry that has previously been used for solid scaffold 
fabrication for the purposes of bone tissue engineering[48, 55, 62, 63]. In addition, the non-
destructive microtomography imaging used in this study better preserves the internal structure of 
the solid scaffolds compared to traditional sectioning techniques. The shear-induced damage that 
can occur with sectioning may affect the pore structure of the interior of the solid scaffold. 
Due to time restrictions, we were unable to ascertain the long-term effects of the PLGA-
IO scaffold material on chondrocyte cultures. The long-term success of PLGA as a scaffold 
material for 3D chondrocyte culture was demonstrated in the 6 month in vivo study by Jiang et 
al[158]. Although information on the long-term effects of IO on chondrocytes is lacking, based 
on the positive results from the  short-term studies done by Farell et al[66] and Heymer et al[65] 
chondrocyte proliferation and phenotype should not be affected by this material. We 
hypothesize, based on the aforementioned PLGA and IO studies, that chondrocytes will respond 
favourably to long-term culture on scaffolds fabricated from this PLGA-IO composite material. 
Another limitation to the present study is the absence of any investigation into the 
phenotype of chondrocytes cultured on the PLGA-IO material. Due to the small culture surface 
area used in this experiment, we felt that all of the cells harvested after one week in culture 
would be required for the Hoechst DNA assay. However, after performing the DNA assay and 
measuring the high levels of cellular DNA, it became apparent that a portion of the harvested cell 
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suspension could have been used either for DMMB sulphated GAG analysis or qPCR. It is 
suggested that future investigations into this scaffold material include some form of investigation 
into chondrogenic phenotype retention. 
For the purposes of our immediate research, we determined that the PLGA-IO scaffold 
material was well-suited for making the solid scaffold portion of our solid/hydrogel composite 
scaffolds. Using the material slurry is advantageous compared to using the high temperature 
polymer melts reported elsewhere[47] because the low-temperature deposition better protects the 
bioactivity of the polymer[48] and eliminates the need to have a rapid prototyper capable of high 
temperatures[159]. This material had greater cell survivability than the previously reported 
PLGA-HAP slurry, and since PLGA-HAP scaffolds have been shown to promote osteogenic 
phenotypes[62], it is presumed that the PLGA-IO will also be better suited for chondrogenic cell 
culture. 
5.2 Hydrogel Preparation and Characterization 
This portion of the project determined whether HA and CS supplements improved 
chondrocyte activity compared to an untreated hydrogel control. This represented the first such 
supplementation study that used a fibrin/alginate hydrogel to suspend the chondrocytes and also 
the first to explore the effects of supplementing cultures with both solubilised HA and CS. The 
concentration of HA and CS (0.1 mg/ml) was chosen as it has been shown to enhance matrix 
production and cell proliferation in HA[21, 22], and matrix production in CS supplemented 
hydrogels[23]. Finally, this represented the first time that the gene expression of chondrocytes 
cultured in fibrin/alginate hydrogels and chondrocytes cultured in monolayer was compared to 
gene expression in freshly isolated chondrocytes. 
After 1 week of culture hydrogels supplemented with CS, HA, or HACS all had roughly 
twice as much µg GAG/µg DNA as untreated hydrogel controls did. Interestingly, the effects of 
the HA and the CS were not additive when they were combined together in the HACS 
supplemented hydrogels, inferring that there was no benefit (with respect to sulphated GAG 
production per cell) to adding both of these macromolecules to the cultures as opposed to just 
treating with one or the other. Unlike the situation in week 1 samples, after 2 weeks of culture 
the amount of GAG/µg DNA within the HA and HACS treated samples was significantly lower 
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than in untreated hydrogels. The CS treated hydrogels were also lower than the controls, though 
not significantly so. In this case effects of the HA and the CS were roughly additive. This 
suggests that individual cells in the supplemented hydrogels were producing more sulphated 
GAG than individual chondrocytes in the non-supplemented hydrogels during the first week, and 
less sulphated GAG during the second week. This eventual inhibition of sulphated GAG 
production is important as it infers that, on a per-cell basis, the supplementation of these 
hydrogels is actually slowing the rate of matrix production. 
The effect of macromolecule stimulation on cell population was also examined in the 
present research. Comparison of the untreated controls for the week 1 and week 2 time points to 
hydrogels harvested initially showed that there was significant increase in cellular DNA during 
the first week but not during the second week. This increase in cellular DNA is interpreted as 
evidence of cell proliferation within the untreated hydrogels. Moreover, since all of the 
supplemented hydrogels had either DNA levels not significantly different from, or significantly 
greater than, the untreated hydrogels this inferred that there was chondrocyte proliferation in all 
treatment groups. This proliferation demonstrates both the biocompatibility of the fibrin/alginate 
hydrogel and the suitability of the cell seeding concentration used. 
The Hoechst data for the week 1 samples showed that all treated hydrogel groups had 
roughly equivalent cell numbers as the untreated control. However, after 2 weeks of culture the 
CS and HACS treated samples both had significantly higher cell populations than the untreated 
controls, with the HA treated sample trending higher than the untreated control, though not 
significantly so. The higher levels of cellular DNA in the supplemented hydrogels after 2 weeks 
may be due to the earlier elevated sulphated GAG levels in the supplemented hydrogels 
harvested after 1 week of culture. This would suggest that while the solubilised CS and HA do 
not have an effect on cell proliferation, the accumulation of ECM molecules produced by the 
chondrocytes may. 
The fact that cell population differed between treatments in the later time point, and that 
many of the previous studies on macromolecule stimulation [21, 22, 24] do not normalise their 
µg GAG readings to cell population, prompted the examination of the unnormalised DMMB 
readings as well. This unnormalised sulphated GAG accumulation data was similar to the 
normalised data in the week 1 samples, but the examination of the unnormalised week 2 data 
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showed that there were not significant differences between the treated samples and the untreated 
hydrogel controls. 
It is probable that the matrix accumulation due to the embedded chondrocytes producing 
their own CS and HA had become so high during the second week that the stimulatory effects of 
the supplemented CS or HA became negligible. The similar levels of unnormalised sulphated 
GAG accumulation in all hydrogels after two weeks of culture regardless of cell population 
could be due to the cells reducing their proteoglycan production in response to the high levels of 
accumulated ECM surrounding them. This trend of decreasing matrix production with matrix 
accumulation was previously reported by van Susante et al.[24] and it would effectively allow 
the untreated hydrogel to “catch-up” to the three different supplementation treatments during the 
second week. This would also account for the lower sulphated GAG production per individual 
chondrocyte in the supplemented hydrogels which is discussed above. This is an important 
distinction, as it suggests that it is not the supplemented CS and HA directly decreasing matrix 
production (per cell) in week 2, but rather the early elevated levels of accumulated ECM which 
are due to the CS and HA supplements. 
The mRNA analysis examined the gene expression of collagen types I and II and 
aggrecan mRNAs relative to GAPDH mRNA expression as an indicator of the production of 
those proteins at the time of cell harvest. The qPCR data showed no significant difference 
between mRNA expression of each of the three genes of interest (collagen types I and II and 
aggrecan) in the treatment groups when compared to the mRNA expression of these genes in the 
untreated control. From this, we infer that at the end of one week of culture none of the 
supplemented hydrogels were producing significantly more collagen type I, II or aggrecan than 
the untreated control.  
The immunostaining data for collagen types I and II (Figure 32) showed a general trend 
of both of these proteins accumulating in the hydrogels over time. This suggests that the mRNAs 
for these collagens that are being detected in the qPCR reaction are in fact being translated into 
proteins. In addition, the fact that the accumulated sulfated GAG levels so drastically increased 
between the week 1 and week 2 samples suggests that the aggrecan mRNA that is being detected 
in the qPCR reaction is being translated into the aggrecan proteoglycan. Visual evidence of this 
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is displayed in the early Alcian Blue staining of chicken sternal chondrocytes as shown in Figure 
37. 
When comparing the mRNA expression of the three genes of interest in chondrocytes 
cultured within non-supplemented hydrogels, and in monolayer on a tissue culture plate for 6 
days or 12 days with the mRNA expression of freshly isolated chondrocytes it became apparent 
that the hydrogel culture helped chondrocytes maintain their phenotype better than culturing in 
monolayer. Collagen type II and aggrecan gene expression is characteristic of hyaline 
chondrocytes while high levels of collagen type I indicate that the chondrocytes are de-
differentiating. Both the untreated hydrogels (week 1) and the day 6 monolayer cultures showed 
a significant up-regulation of the aggrecan and collagen type II genes, while the chondrocytes 
cultured in monolayer for 12 days had collagen type II mRNA levels significantly lower than the 
freshly isolated chondrocytes. A visual indication of how much better the hydrogel helps 
chondrocytes maintain their phenotype is provided in Figure 30b, which shows that the collagen 
type I gene is much more strongly expressed in chondrocytes expanded out on a tissue culture 
plate than those cultured in the hydrogel. 
If one was to view the amount of collagen type II mRNA relative to the amount of 
collagen type I mRNA as a sort of “differentiation index” as has been previously suggested[154, 
160], then the data presented in Figure 31 provides an excellent perspective on how the 
chondrocytes are maintaining their phenotype. The freshly isolated chondrocytes expressed 
collagen type II mRNA at over 200 times the level of collagen type I mRNA. Though 
chondrocytes in the untreated hydrogels had a higher collagen II/collagen I expression ratio 
(approximately 12:1) than the chondrocytes in monolayer cultures, the ratio was much lower 
than for freshly isolated chondrocytes. This portion of the gene analysis suggests that while 
hydrogel cultures help chondrocytes retain their phenotype better than traditional culture 
techniques, there is most likely some de-differentiation of a portion of the chondrocyte 
population. 
The early (week 1) results for normalised sulphated GAG accumulation and cellular 
DNA for the aforementioned full hydrogel experiment showed similar results to the preliminary 
pilot experiment. The primary difference between these experiments was sample size, with the 
full experiment having 7 samples and the preliminary study having 3 samples per treatment 
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group. In addition, the preliminary experiment was harvested at 10 days rather than 1 and 2 
weeks. The one discrepancy in the results was that the preliminary pilot experiment showed that 
there were significantly fewer chondrocytes in the HA supplemented hydrogels compared to 
non-supplemented hydrogel controls. However, it was still only 15% less than the untreated 
control, which makes one question whether or not an effect size this small is actually biologically 
relevant. In addition, the week 1 HA supplemented samples of the more comprehensive full 
hydrogel supplementation experiment were not significantly different from the non-
supplemented hydrogels, giving us further confidence that the early effect on HA on chondrocyte 
population, if any, is minimal. 
The early elevated sulfated GAG levels in samples treated with CS relative to non-
supplemented hydrogels in the week 1 (Figure 26) samples was not found in a previous study by 
van Susante et al.[24]. In contrast, the week 2 GAG/µg DNA data reported by this same study 
showed a similar result to those seen within the present work while the study put forward by 
Bassleer et al.[23] on clustered cultures of human chondrocytes showed significantly more 
GAG/µg DNA after 16 days of culture in samples treated with CS than in non-supplemented 
controls. 
Both the studies presented by Kawasaki et al.[22] and Akmal et al.[21] found that there 
was no significant difference in GAG production after 1 week of culture and significantly more 
GAG production in HA treated samples cultured for 2 weeks, relative to untreated hydrogels. 
This differs from the results reported in Figure 26, which show a significantly higher amount of 
GAGs in the HA treated samples at week 1 and no significant difference between the HA treated 
samples and controls after 2 weeks of culture. This discrepancy may be due to the chondrocytes 
producing sulphated GAG at a faster rate in the fibrin/alginate hydrogel as opposed to the 
alginate or collagen I hydrogels used in these other studies. This would lead to a higher early 
accumulation of sulphated GAG in our study, with matrix production decreasing with increasing 
matrix accumulation as described above. 
The DNA levels in CS treated hydrogels closely matched those reported in the van 
Susante et al. study[24]. Namely, samples treated with CS have previously been shown to have 
similar cell populations to non-supplemented hydrogel controls after 1 week of culture, but a 
significantly higher cell population after 2 weeks. 
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The literature is ambiguous when showing the short-term effect of HA supplementation 
on chondrocyte numbers in hydrogel culture with Akmal et al.[21] stating no significant 
difference in cell population after 1 week, while Kawasaki et al.[22] show a significantly higher 
cell population compared to non-supplemented hydrogel cultures. Our results closely correspond 
to the week 1 cellular DNA results presented by Akmal et al[21].  
The literature is slightly more consistent regarding the effects of HA supplementation 
after 2 weeks of hydrogel culture relative to non-supplemented controls, with both of the 
aforementioned HA supplementation studies showing a significantly higher cell population after 
2 weeks of culture, and a third study by Nishimoto et al. not showing a significant 
difference[161]. Though the week 2 DNA levels in the HA treated hydrogels were not 
significantly higher than untreated hydrogels, there was certainly a trend in the same direction, as 
shown in Figure 25, suggesting that our results correspond with those found in the literature. 
Both the Nishimoto and van Susante findings for the effect of CS supplementation on 
gene expression were similar to what we report in this study (Figure 29). In the study performed 
by Nishimoto et al.[161], they found that after two weeks of culture in a collagen hydrogel 
supplemented with CS there was not a significant difference in either collagen type II or 
aggrecan mRNA expression. Van Susante et al.[24] also measured how much S35 uptake there 
was over a three hour period in both non-supplemented samples and samples treated with CS. 
This, like the mRNA analysis for aggrecan is an indicator of how many PGs are being produced 
at a certain point of time. The van Susante study showed that there was no significant difference 
in S35 uptake between the two treatments at both 1 and 2 weeks of culture[24]. When 
supplementing collagen hydrogels with HA, Nishimoto et al. did find a significant decrease in 
both aggrecan and collagen type II expression compared to untreated controls, which conflicts 
with the data found in the present work[161]. In addition, the dramatic increase in collagen type I 
mRNA and the initial increase and then eventual decrease in collagen type II mRNA in 
chondrocytes cultured in monolayer, reported in Figure 29, was also seen by Marlovits et 
al.[154]. 
There are a number of possible reasons for why some of the data reported within the 
present work does not align perfectly with those reported in the literature. For one, almost all of 
these studies with the exception of Nishimoto et al.[161] did not use porcine chondrocytes. There 
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may be differences in how newborn porcine chondrocytes react to this type of supplementation 
when compared to human or bovine adult specimens. Another reason could be that none of the 
other studies mentioned in this discussion section used the same type of three dimensional 
culturing material that was presented in this thesis. It has been shown previously, that the type of 
hydrogel used[105], or the use of a solid scaffold instead of a hydrogel[40, 57, 59] can greatly 
impact chondrocyte behaviour. Finally, the cell seeding density used in this study was different 
from the ones used in most of the other aforementioned macromolecule supplementation 
experiments[22-24, 161]. It has been shown that initial cell seeding density also has a significant 
effect on chondrocyte matrix accumulation and proliferation[32, 33]. 
A major strength of our study was that both gene expression and matrix accumulation of 
collagen type I, collagen type II and aggrecan was tested. This allowed us to ascertain in depth 
how well the chondrocytes were retaining their phenotypes in different culture conditions. 
Another strength was in the choice of the fibrin/alginate hydrogel, which provided a better long-
term environment for chondrocyte culture than fibrin or alginate hydrogels alone would 
have[42]. 
One technical limitation we encountered was that the immunostaining signal intensity 
depended greatly on the quality of the section being stained. If the section was torn, or parts of it 
washed off during the staining process it would reduce the intensity of the final stain. It is likely 
that this variability was responsible for not being able to see significant differences between the 
non-supplemented hydrogel cultures and those treated with macromolecules. On the other hand, 
the expression of these proteins may truly not be affected by supplementation with CS and HA. 
Another limitation was the small number of samples for the chondrocytes cultured in 
monolayer and freshly isolated chondrocytes. For example, the collagen type I expression for the 
day 12 culture was not as significantly different from collagen type I gene expression in freshly 
isolated chondrocytes even though its median value was over 1300 times higher. The reason for 
this is that for low samples sizes (such as n=3) the randomization test can be quite conservative. 
However, with an effect of this magnitude, it seems likely that if more samples had been 
analysed, a significant difference would have been detected. 
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Finally, while the gene expression data provided valuable information about how well the 
chondrocytes were retaining their phenotype, it failed to show the stimulation that caused the 
early matrix accumulation in the supplemented hydrogels. The gene expression analysis may 
have captured this stimulation if a set of samples had been harvested halfway through week one. 
This study showed that, although HA and CS supplementation had a short-term 
stimulatory effect on sulphated GAG production, these effects were not additive and were short-
lived. This suggests that it is not worth the expense of adding both stimulants to the medium. 
While the HA and CS both elicited roughly the same early matrix accumulation, the CS treated 
hydrogels had higher levels of cell proliferation after 2 weeks. This increase in cell numbers is 
important for integration with the surrounding tissue[162] when constructs are implanted in vivo. 
For the immediate purposes of this study, we have shown that since the preliminary composite 
solid/hydrogel scaffold experiment only has a culture time of one week, it would be 
advantageous (with regards to sulphated GAG production) to supplement the fibrin/alginate 
hydrogel with either CS or HA. 
Current engineered cartilage still has matrix accumulation well below the levels seen in 
native cartilage[50]. The mechanical properties[70], cell proliferation and integration with the 
surrounding tissue[162] are all correlated with this matrix accumulation making it crucial to 
continue developing techniques that promote cell growth and matrix production. 
5.3 Composite Scaffold Experiments 
The purpose of this portion of the study was to demonstrate the higher cell survivability 
and matrix accumulation in composite solid/hydrogel scaffolds relative to solid scaffolds seeded 
with the same number of chondrocytes. This represents the first time that PLGA-IO has been 
used as the solid scaffold material and fibrin/alginate has been used as the hydrogel in a 
composite scaffold. 
The impregnation of the PLGA-IO solid scaffolds with the fibrin/alginate hydrogel 
proved to be successful, as shown in Figure 33. The DMMB assay gave a significantly stronger 
signal for the composite scaffolds than for solid scaffolds that were not impregnated with a 
hydrogel. Moreover, the Hoechst DNA assay showed that there was significantly more cellular 
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DNA in the composite scaffold than in the solid scaffold controls. However, it is not believed 
that these readings are actually due to the superiority of the composite scaffolds over solid 
scaffolds without hydrogels. 
As mentioned in Section 3.3.2, the standard curve for the DMMB assay was constructed 
using a set of standards made from dissolved fibrin/alginate hydrogels supplemented with a 
known amount of CS. Alginate contains a carboxyl group which competes with the sulphate 
group on the sulphated GAGs to create complexes with the DMMB dye molecules. The effect of 
these carboxyl groups is minimized by lowering the pH of the assay to 1.5 as demonstrated by 
Enobakhare et al[150]. However, the fact that the solid scaffold controls (without fibrin/alginate 
hydrogel) yielded a DMMB reading less than the 0 µg CS standard suggests that although the 
effects of the alginate on the DMMB assay had been minimized, the alginate still caused a 
background reading. Accordingly, the solid scaffold controls which contained no alginate would 
produce a lower DMMB reading than would a CS standard (with alginate) with a similar 
concentration of CS. 
The aforementioned background reading due to the alginate means that one cannot use 
the dissolved hydrogel standards to accurately determine the level of sulphated GAGs in a 
sample that does not contain an equivalent amount of alginate. Accordingly, the GAG levels in 
the solid scaffold controls cannot be determined using the standard curve constructed with 
dissolved fibrin/alginate hydrogels standards. However, since the composite scaffolds and 
hydrogel standards had an equivalent concentration of alginate, the standards were a fair 
representation of these samples. Therefore, the fact that the composite scaffold reading was 
essentially the same as the 0 µg standard suggests that there was indeed not a detectable amount 
of GAG accumulation during the week of culture in the composite scaffolds. 
It should be noted that the DNA readings obtained from the Hoechst assay were much 
lower than expected based on the large numbers of cells seeded in both the composite scaffolds 
and the solid scaffolds not impregnated with hydrogel. The DNA levels in the 3D solid scaffold 
controls (Figure 35) were much lower than when a similar number of cells were cultured on 
flattened disks of the PLGA-IO scaffold material, as presented in Figure 20. Since the 
dissociated chondrocytes were frozen in almost the exact same amount of Hanks’s saline one 
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would not expect to see only 6% of the DNA in the solid scaffold controls compared to the 
earlier substrate experiment. 
This low Hoechst reading and the fact that no GAG accumulation was detected suggests 
that many of the cells initially seeded in both the composite scaffolds and solid scaffolds did not 
survive the week in culture. This cell death is almost certainly not due to either the PLGA-IO 
scaffold or the fibrin-alginate hydrogel materials themselves, as my earlier experiments had 
shown that chondrocytes could be successfully cultured on these materials for at least a week. 
The most likely explanation is that a large proportion of the chondrocytes died during the initial 
cell seeding process into both scaffold types. The cells had been subjected to a Trypan Blue dye 
exclusion assay prior to seeding which showed that the chondrocytes were initially viable. 
However, after the high cell density overnight incubation to allow the cells to attach to the solid 
scaffold controls, it was observed that the Phenol Red indicator in the culture medium had turned 
from red to yellow, indicating that the culture medium had acidified. After the composite 
scaffolds and the solid scaffold controls were transferred to fresh tissue culture dishes, the cells 
remaining in the original plates were subjected to a Trypan Blue viability assay which confirmed 
that over 95% of the cells were dead (results not shown). 
The concentrated cell suspension used during the seeding process described in Section 
3.4.1 may have depleted the DMEM of nutrients which led to chondrocyte death and cell lysates 
being released into the medium, causing acidification. On the other hand, the small volume of 
culture medium may have become inundated with acidic metabolites which caused the 
chondrocytes to lyse. In either case, since both the solid scaffold controls and the composite 
scaffolds experienced roughly the same levels of cell death, it is unlikely that the hydrogel 
impregnation process killed the cells but rather the high cell seeding density. This acidification 
may be ameliorated by using a less concentrated cell suspension, or by using a medium perfusion 
system that constantly exchanges the medium. 
The low number of viable cells is almost certainly the cause of the undetectable matrix 
accumulation and the low Hoechst readings. Though the Hoechst assay indicates a greater cell 
population in the composite scaffolds, it is unclear whether this is due to the superiority of the 
composite scaffold or not. It could be that the hydrogel was able to better protect the cells from 
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medium acidification, or was able to better preserve the DNA within dead cells so that it could 
be detected by the Hoechst assay. 
As mentioned earlier, this was a preliminary experiment and as such, had a number of 
limitations. First, the aforementioned cell death during seeding made it impossible to ascertain 
matrix accumulation and confidently say whether the DNA levels actually reflected improved 
chondrocyte retention and survivability. However, previous studies by Lee et al.[69]  and Gong 
et al.[59] showed significantly higher sulphated GAG accumulation and cell population 
immediately after seeding and after 1 week of culture in composite scaffolds compared to 
chondrocytes cultured in solid scaffolds not impregnated with hydrogel. In addition, this 
preliminary experiment lacked a gene analysis portion which would be a powerful indicator of 
matrix production at the time of harvest. Malicev et al[68]. performed a gene analysis on human 
chondrocytes in composite scaffold culture for 3 weeks using the same target genes analysed in 
our hydrogel supplementation experiments and found that collagen type II and aggrecan were 
upregulated relative to solid scaffold controls, while collagen type I levels were not significantly 
different. Finally, while this short-term in vitro experiment would shed little light on how these 
composite scaffolds would perform for extended periods of time in vivo, there are previously 
published studies by Fan et al.[39] and Eyrich et al.[40] which showed that composite scaffolds 
had superior ECM production and integration with the surrounding tissue after 6 months of in 
vivo culture compared similarly implanted solid scaffold controls. 
The composite scaffold reported here has the potential to be a significant improvement 
over other previously manufactured composite scaffolds [39, 40, 57, 59, 68, 69]. As mentioned 
in Section 5.1, the PLGA-IO solid scaffold can be fabricated at low temperatures and is more 
cytocompatible than PLGA-HAP. Moreover, there is evidence that this solid scaffold material 
will better help chondrocytes preserve their phenotype[62, 65, 66]. In addition, the fibrin/alginate 
hydrogel utilized here has been shown have better long-term stability than the fibrin hydrogel 
commonly used in composite scaffolds[42]. Composite scaffolds have previously shown 
enhanced cytocompatibility and mechanical properties over solid scaffold and hydrogel controls, 
respectively[59, 70]. Therefore, these scaffolds show great promise in moving cartilage tissue-
engineers toward their goal of a long-term, mechanically stable, and cytocompatible engineered 
cartilage.  
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Chapter 6: Conclusions and Future 
Directions 
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6.1 Conclusions 
Based on the aforementioned findings it can be concluded that the PLGA-IO material 
slurry is suitable for creating scaffolds with porous structure and that a dried film of this slurry 
has the ability to support chondrocyte culture. The fact that this material had significantly more 
cells on it than a PLGA-HAP film seeded with an identical number of chondrocytes suggests that 
this may be a significant advancement in the study of possible scaffold materials for use in tissue 
engineering scaffolds. 
The results of the macromolecule supplementation experiment indicated that there was an 
initial stimulatory effect on sulphated GAG production when chondrocytes were cultured in 
fibrin/alginate hydrogels containing HA and/or CS. However, this stimulation of GAG 
production was not seen in the hydrogel samples cultured for 2 weeks, suggesting that the effects 
of treating the HA and CS supplements are short-lived.  
The higher initial GAG accumulation in the HA, CS, and HACS supplemented hydrogels 
relative to non-supplemented controls may have stimulated higher chondrocyte proliferation in 
these supplemented hydrogels during the second week of culture. This proliferation may be due 
to enhanced cell-cell interactions via the freshly synthesized ECM. 
Since the effects of HA and CS were not additive it appeared that, for the most part, there 
was no advantage to treating with both HA and CS together. Therefore, it is not worth the extra 
expense of adding both components. The HA and CS supplements elicited roughly the same 
initial stimulation of matrix accumulation. However, in the week 2 samples, the CS treated 
hydrogels had a higher cell population and final matrix accumulation than HA supplemented 
hydrogels (unnormalised). This suggests that of the treatments examined here, supplementing 
with 0.1 mg/ml CS has the most beneficial effects on chondrocyte proliferation and phenotype 
retention. 
A method for impregnating the solid scaffolds with the fibrin/alginate hydrogel was 
successfully implemented, as shown in Figure 33. However, the preliminary experiment did not 
definitively show that the composite scaffolds had higher sulphated GAG accumulation and cell 
population than solid scaffold controls as a large number of the cells died off during the seeding 
process. Previous studies [39, 40, 57, 59, 68, 69] which examined composite scaffolds with 
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different solid scaffold materials and hydrogels have demonstrated the superiority this culture 
method over solid scaffolds not impregnated with hydrogels. Therefore, if the seeding process 
can be modified to enhance cell survival the superior matrix production and cell population in 
these composite scaffolds should also be demonstrated here. 
6.2 Future Directions 
The next step of the solid scaffold material research should be to repeat the substrate 
experiment and do a gene analysis of the chondrocytes cultured on these materials. This gene 
analysis should examine the same target genes as the qPCR analysis used in the hydrogel 
supplementation experiment (collagen type II, aggrecan, and collagen type I normalised to 
GAPDH). This will help confirm which of the materials are helping the chondrocytes maintain 
their phenotype the best. 
Since the porosity of these solid scaffolds differed from the designed porosity, it would 
be of interest to see how closely they coincide with the more detailed pore size model put 
forward by Li et al.[163] which takes into account the fusion of the layers. If it is found that the 
calculated pore sizes still differ significantly from the ones measured by microtomography, then 
it may be of interest to create a mathematical model that also takes the shrinking of the scaffolds 
as they dry into account. With this model, the fabricators of TECs would be able to more 
accurately design for the final pore sizes of the solid scaffolds. 
To further elucidate the effects of the CS and HA macromolecules on hydrogel cultured 
chondrocytes it would be of interest to examine the mRNA expression halfway through the first 
week to see if the cells in the treated hydrogels were more strongly expressing the collagen type 
II and aggrecan mRNA than the untreated control. In addition, examining the mRNA expression 
halfway between the week 1 and week 2 time points would allow one to see if the untreated 
controls were in fact more strongly expressing the aggrecan mRNA as it “catches up” to the 
other treatments. It would also be interesting to see whether or not the hydrogels had reached 
their steady-state values for cell population and matrix accumulation by taking some later time 
points for biochemical analysis. 
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The doses of CS and HA chosen here were previously reported to be optimal for the 
enhancement of matrix production and cell proliferation in HA[21, 22], and matrix production in 
CS supplemented hydrogels[23]. However, it would be of interest to know if adjusting these 
doses would have an impact on the interaction of the effects of HA and CS supplementation. In 
addition, a study by Hwang et al.[164] explored the effects of copolymerizing HA and CS with 
hydrogels. This copolymerization reduces the solubility of these supplements and, like the 
present study, showed an increase in sulphated GAG accumulation compared to hydrogels that 
were not copolymerized. This copolymerization method may be better suited to in vivo studies of 
these supplemented hydrogels, as they would allow the macromolecules to be better retained by 
the hydrogel after implantation. 
It would also be of interest to directly compare the efficacy of stimulating chondrocytes 
with HA and CS relative to different growth factors currently in use by cartilage tissue engineers. 
Some of these include: transforming growth factor betas [14-17], bone morphogenetic proteins 
[15, 18, 19], fibroblast growth factor 2, and insulin-like growth factor 1[15, 17]. 
The large amount of cell death during the seeding process in the composite scaffold 
experiment may be ameliorated by lowering the chondrocyte concentration to reduce the 
acidification of the culture medium. If the cell concentration is lowered, it may be necessary to 
increase the size of the constructs so that there is a detectable amount of sulphated GAG and 
cellular DNA. In addition, a medium change during the seeding process or a medium perfusion 
system would reduce the depletion of media nutrients and the accumulation of toxic metabolites. 
To ensure that the DMMB assay is accurately measuring the GAG production in the solid 
scaffold controls it is recommended to create a second set of standards that are a known amount 
of CS in Hank’s saline. This second set of samples would be used to measure the GAG 
production in the solid scaffold controls while the existing set of standards would still be used to 
measure GAG production in the composite scaffolds. 
Once cells can be successfully cultured in the composite scaffolds and sulphated GAG 
accumulation can be measured, it would be of interest to measure the mechanical properties of 
these scaffolds using the methods outlined in Chapter 2. The small amount of mechanical testing 
that has been done on composite scaffolds[59] fails to report properties such as hydraulic 
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permeability and aggregate modulus, which are important for comparison to the mechanical 
behaviour of natural cartilage. Once known, these properties could be modified to more closely 
match those of native cartilage using the various methods outlined in Section 2.2.6. 
While testing the short-term behaviour of porcine chondrocytes in composite scaffolds in 
vitro provides a relatively simple measure of their efficacy, before these scaffolds can be used to 
treat patients with osteoarthritis a number of research milestones must be achieved. First, the 
long-term (1 to 6 month) in vivo culture of these constructs would show if chondrocytes were 
stably maintaining their phenotype and viability. These composite scaffolds and solid scaffold 
controls could be implanted in articular defects in a model animal to compare their rate of 
degradation and rate of integration with the surrounding native cartilage. 
The porcine chondrocytes used here served as a suitable model for these early 
investigations. However, the use of primary human chondrocytes would provide further insight 
into the potential of these composite scaffolds to create a cartilaginous tissue suitable for 
implantation into humans. Another potential cell source is bone-marrow derived stem cells 
which could be induced into differentiating into chondrocytes by supplementing either CS, HA, 
or other ECM components, or growth factors (such as TGF-βs, BMPs, FGF-2, etc). 
Once these composite scaffolds have the appropriate mechanical properties, been proven 
capable of supporting human chondrocyte culture, and have an appropriate regimen of 
supplements they could prove to be an effective treatment for patients suffering from 
osteoarthritis. 
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